A fast genetically encoded fluorescent sensor for faithful in vivo acetylcholine detection in mice, fish, worms and flies by Borden, Philip M. et al.
A fast genetically encoded fluorescent sensor for faithful in vivo acetylcholine detection in mice, 
fish, worms and flies 
Philip M. Borden1,26,$, Peng Zhang2,$, Amol V. Shivange1,3, Jonathan S. Marvin1, Joseph 
Cichon4,5, Chuntao Dan1, Kaspar Podgorski1, Antonio Figueiredo6, Ondrej Novak1,27, Masashi 
Tanimoto1, Eiji Shigetomi7,8, Mark A. Lobas7,28, Hyuntae Kim9, Paula K. Zhu10,11, Yajun Zhang2, 
W. Sharon Zheng2,12, ChengCheng Fan13, Guangfu Wang2, Bowen Xiang2,14, Li Gan15, Guang-
Xian Zhang16, Kaiming Guo2,17, Li Lin17, Yuan Cai18, Andrew G. Yee18, Abhi Aggarwal1,19, 
Christopher P. Ford18, Douglas C. Rees13,20, Dirk Dietrich9, Baljit S. Khakh7, Jeremy S. 
Dittman21, Wen-Biao Gan4, Minoru Koyama1, Vivek Jayaraman1, Joseph F. Cheer6,22,23, Henry 
A. Lester3, J. Julius Zhu2,24,25,*, Loren L. Looger1,* 
1 Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA 
2 Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, 
Virginia, USA 
3 Division of Biology and Biological Engineering, California Institute of Technology, Pasadena 
California, USA 
4 Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New 
York, New York, USA 
5 Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, 
Pennsylvania, USA 
6 Department of Anatomy and Neurobiology, University of Maryland School of Medicine, 
Baltimore, Maryland, USA 
7 Department of Physiology and Department of Neurobiology, David Geffen School of 
Medicine, University of California, Los Angeles, California, USA 
8 Department of Neuropharmacology, University of Yamanashi, Yamanashi, Japan 
9 Department of Neurosurgery, University Clinic Bonn, Bonn, Germany 
10 Math, Engineering & Science Academy Class of 2020, Albemarle High School, 
Charlottesville, Virginia, USA 
11 Summer Secondary School Neurobiology Class of 2019, Harvard University, Cambridge, 
Massachusetts, USA 
12 Biomedical Engineering Class of 2021, University of Virginia School of Engineering and 
Applied Sciences, Charlottesville, Virginia, USA 
13 Division of Chemistry and Chemical Engineering, California Institute of Technology, 
Pasadena, California, USA 
14 Biomedical Engineering Class of 2020, University of Virginia School of Engineering and 
Applied Sciences, Charlottesville, Virginia, USA 
15 Helen and Robert Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine 
College, New York, New York, USA 
16 Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA 
17 School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China 
18 Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, 
USA 
19 Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada 
20 Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California, 
USA 
21 Department of Biochemistry, Weill Cornell Medical College, New York, New York, USA 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2020.02.07.939504doi: bioRxiv preprint first posted online Feb. 8, 2020; 
22 Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, 
USA 
23 Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland, 
USA 
24 School of Medicine, Ningbo University, Ningbo, China 
25 Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, 
Netherlands 
26 Current address: LifeEDIT, Research Triangle Park, North Carolina, USA 
27 Current address: Second Faculty of Medicine, Charles University, Prague, Czech Republic 
28 Current address: Koniku Inc., Berkeley, California, USA 
$ Co-first authors 
* corresponding authors: loogerl@hhmi.org or jjzhu@virginia.edu  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2020.02.07.939504doi: bioRxiv preprint first posted online Feb. 8, 2020; 
Abstract 
Here we design and optimize a genetically encoded fluorescent indicator, iAChSnFR, for the 
ubiquitous neurotransmitter acetylcholine, based on a bacterial periplasmic binding protein. 
iAChSnFR shows large fluorescence changes, rapid rise and decay kinetics, and insensitivity to 
most cholinergic drugs. iAChSnFR revealed large transients in a variety of slice and in vivo 
preparations in mouse, fish, fly and worm. iAChSnFR will be useful for the study of 
acetylcholine in all animals. 
 
Introduction 
Acetylcholine (ACh) is a critical neurotransmitter in all animals. Among invertebrates, it 
is the most prevalent excitatory transmitter in the brain, sensory ganglia, and frequently the 
neuromuscular junction (NMJ). Among vertebrates, only a minority of neurons release ACh, but 
these signals play varying key roles. For instance, ACh signals at the NMJ, in the autonomic 
nervous system, and in subsets of the central nervous system, particularly projections arising 
from the brainstem and basal forebrain. Other cholinergic neuron populations in the brain include 
striatal interneurons, the stria vascularis-medial habenula-interpeduncular nucleus pathway, and 
sparse, incompletely characterized cell types such as intrinsic cholinergic interneurons in cortex1 
and hippocampus2. ACh helps to regulate attention3 and wakefulness4, and participates in 
memory formation and consolidation5. ACh is also an important transmitter in glia, and between 
the nervous and immune systems6. 
Acetylcholine is synthesized pre-synaptically from choline and acetyl-CoA by choline 
acetyltransferase (ChAT), then packaged into synaptic vesicles by the vesicular acetylcholine 
transporter (VAChT). A key, partially understood aspect of cholinergic signaling is co-release 
with other neurotransmitters, including GABA, ATP, and glutamate7,8. To understand the role of 
co-release, one must measure ACh release alongside emerging measurements of other 
neurotransmitters. 
Acetylcholine receptors are among the most diverse neurotransmitter receptor families. 
Humans possess five muscarinic G protein-coupled receptors (GPCRs) for ACh (mAChRs) with 
diverse expression in the brain and smooth, cardiac, and skeletal muscle. Vertebrate nicotinic 
ACh receptors (nAChRs) are pentameric ligand-gated cation channels. Humans have a total of 
17 nAChR subunit genes, in five classes: 10 a, 4 b, and one each of g, d, and e. nAChRs occur 
with many subunit combinations9, and others may be undiscovered. Invertebrates also have ACh-
gated chloride channels. On neurons, receptors can be localized pre-, post-, and extra-
synaptically, often with different isoforms in each place10. 
 ACh released at or near synapses is inactivated primarily via hydrolysis to choline by 
acetylcholinesterase (AChE)11.  Numerous molecules, both naturally occurring and synthetic, 
bind to and perturb VAChT, AChRs, or AChE. Cholinergic drugs are used to treat 
neurodegenerative conditions such as Parkinson's disease and Alzheimer’s disease, 
neuromuscular diseases like myasthenia gravis, autoimmune disorders such as asthma and 
rheumatoid arthritis, substance abuse disorders including nicotine addiction, and autonomic 
diseases such as incontinence and nausea12. Most cholinergic drugs have side effects stemming 
from the broad expression, function, and diversity of ACh signaling. Several insecticides and 
chemical warfare agents block AChE. A better understanding of ACh signaling is thus necessary 
for the design and development of improved pharmaceuticals and agricultural products. 
Although ACh was discovered at the beginning of the 20th century13, methods for ACh 
detection are scant. ACh receptors themselves give an imperfect spatial and temporal report on 
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the presence of ACh, because (a) ACh receptors are located at various distances between 0.1 μm 
and ~ 50 μm from the release point (at the neuromuscular junction and in cardiac muscle, 
respectively), and (b) because ACh receptors show a delay ranging from a few μs to several tens 
of ms (and nAChRs and mAChRs, respectively) after ACh is applied nearby14. Indeed, despite 
the widespread presence of many nAChR subtypes in the vertebrate CNS, direct recordings of 
postsynaptic responses are quite rare at nicotinic synapses stimulated pre-synaptically; and direct 
recording of ACh release is needed to understand cholinergic signaling.   For half a century, the 
most sensitive assay for acetylcholine was observation of its stimulatory effect on leech muscle 
treated with eserine (an AChE inhibitor). Advances in chemical derivatization and 
chromatography permitted its direct detection in the 1960s15, but this technique has very poor 
spatial and temporal resolution. Other methods detect ACh electrochemically – an inherently 
slower, indirect technique without molecular specificity16. Improvements in ACh detection have 
come from the development of semisynthetic, FRET-based probes17,18 and whole cell-based 
fluorescence reporters19, but these are limited by low signal change, poor spatial and temporal 
resolution, and difficulty in delivery. 
 Protein-based biosensors allow targeted expression in cells, and even sub-cellular 
compartments, of interest. A recently published sensor (GACh2.0)20 couples ACh binding to a 
change in the fluorescence of circularly permuted green fluorescent protein (cpGFP) inserted 
within an intracellular loop of the M3 mAChR. GACh2.0 has an apparent ACh affinity of 700 
nM, a maximal fluorescence increase of ~80% in cultured cells, and kinetics of ~200 ms trise and 
~700 ms tdecay20. GACh2.0 was validated in neuronal culture, organotypic hippocampal slice, and 
acute slice, with resolvable differences in acetylcholine release being detected on the micrometer 
scale of a single soma. In vivo, GACh2.0 can detect odor-induced acetylcholine release with 2-
photon microscopy in sub-regions of the Drosophila melanogaster antennal lobe. It also detected 
acetylcholine release in mouse visual cortex. However, molecular characteristics of the GACh2.0 
sensor restrict its utility. Foremost, in flies and mice GACh2.0 requires seconds for the onset and 
decay of ACh responses20. This precludes resolution of faster signaling events, hinders detection 
of sparse events, and thus renders GACh2.0 essentially a binary detector of ACh within a region 
of interest over several seconds. Moreover, the sensor responds (positively or negatively) to all 
molecules that normally bind the M3 receptor, precluding the use of GACh2.0 in combination 
with many cholinergic drugs. Finally, over-expression of GPCRs perturbs the function of 
endogenous proteins such as G-proteins21,22 and can disrupt cellular behavior23, creating concerns 
that GACh2.0-expressing cells may have altered ACh and/or other signaling pathways. 
 In a complementary strategy, we have coupled ligand binding to fluorescence with nearly 
modular fusion proteins. These utilize microbial periplasmic binding proteins (PBPs) as the 
molecular recognition moiety and circularly permuted GFP or its analogs as the reporter 
moieties. The strategy has created sensors for glutamate (iGluSnFR24, SF-iGluSnFR25), GABA 
(iGABASnFR)26, glucose (iGlucoSnFR27, iGlucoSnFR-TS28), maltose29, and phosphonate30. 
Because of their basis on microbial proteins, they are bio-orthogonal to endogenous signaling 
pathways in model organisms, permitting both long-term in vivo expression and use alongside 
most relevant pharmaceuticals. Sensors derived from PBPs generally have rise and decay 
kinetics on a millisecond time scale approaching that of postsynaptic ligand-gated ion channels, 
thus permitting useful imaging at >1 kHz24,30,31, appropriate to millisecond-scale 
neurotransmission. 
 Here we extend the collection of PBP-based sensors to include an intensity-based 
acetylcholine sensing fluorescent reporter, iAChSnFR. iAChSnFR detects ACh with low-
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2020.02.07.939504doi: bioRxiv preprint first posted online Feb. 8, 2020; 
micromolar affinity and 12-fold maximal fluorescence change in vitro (4.5-fold change in 
neuronal culture), has millisecond-level activation and decay kinetics, is orthogonal to most 
cholinergic drugs, and is available as both green and yellow fluorescent versions. iAChSnFR 
detects ACh release in vivo in the brains of mice, fish, and flies, and at the worm NMJ. In mouse 
cortex in vivo, iAChSnFR tracked running-dependent cholinergic modulation from basal 
forebrain, localizing ACh transients with spatial and temporal resolutions of tens of milliseconds 
and <1 µm). Imaging in visual cortex confirmed these results, and further demonstrated depth-
dependent modulation by isoflurane anesthesia. Acetylcholinesterase inhibitors increased signals, 
and a non-binding sensor showed no response, together demonstrating that iAChSnFR 
specifically measures ACh. iAChSnFR will be useful for numerous experiments across model 
organisms. 
 
Results 
 
Sensor engineering. 
We previously developed a generalizable technique for developing intensity-based 
fluorescence sensors from solute-binding proteins that undergo a Venus flytrap-like 
conformational change29. Several such proteins that bind choline and/or betaine have been 
characterized biochemically and structurally. We first developed a sensor based on the 
acetylcholine/choline-binding protein ChoX from the soil bacterium Sinorhizobium meliloti31, 
but choline-dependent fluorescence increases were unacceptably slow (minutes; not shown). We 
developed another sensor from the Bacillus subtilis choline-binding protein OpuBC32, but when 
expressed in mammalian cells with membrane-targeting motifs, it aggregated in the endoplasmic 
reticulum (not shown). 
We identified a hyperthermophilic homologue of B. subtilis OpuBC, from 
Thermoanaerobacter sp. X513 (38% overall identity; 4/9 key ligand-binding residues conserved; 
5/9 similar; Supp. Fig. S1). Isothermal titration calorimetry of purified X513-OpuBC confirmed 
binding of choline (Kd = 8 µM) and acetylcholine (Kd = 95 µM) (Supp. Fig. S2). This 
thermophilic scaffold provided the basis for iAChSnFR. 
 Insertion of circularly permuted Superfolder GFP (SFGFP)33 after residue Gly106, 
followed by optimization of the binding protein-GFP linkers, yielded an initial variant 
(iAChSnFR0.4; Supp. Fig. S3) with an apparent Kd of 220 ± 16 µM for ACh and a total 
fluorescence increase (∆F/F)max of ~0.7, but with tighter affinity for choline and betaine (not 
shown). A crystal structure of the unliganded/open form of iAChSnFR0.4 showed the expected 
structural homology with B. subtilis OpuBC34 and with several other choline-binding PBPs (PDB 
1SW1, 3R6U, 2REG, 2RIN). 
Guided by the ligand-free crystal structure of this initial variant (Fig. 1a), we extensively 
screened for variants with increased specificity and affinity for ACh and increased ∆F/F upon 
saturation with ACh. Intermediate variants included iAChSnFR0.6 and iAChSnFR0.7; Supp. 
Fig. S3). The final variant, iAChSnFR0.9 (hereon referred to as iAChSnFR) has five binding-site 
mutations to the starting scaffold. iAChSnFR also has three mutations on the periphery of the 
binding site, two mutations in the “hinge” to shift the open-closed equilibrium35, four mutations 
to the proto-interface between X513 and cpSFGFP, and seven mutations to the junctions between 
the binding protein and cpSFGFP (Supp. Fig. S3). We solved the crystal structure of the ACh-
bound/closed state of X513 OpuBC, without the GFP (Fig. 1b), revealing the importance of 
mutations such as Phe219Trp and Glu174Phe (aromatic cage around choline), Arg178Gly 
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(creates space for acetyl moiety), and Lys39Ile (creates space for and hydrophobic contact with 
acetyl). iAChSnFR binds acetylcholine with an apparent Kd of 1.3 ± 1.0 µM, (∆F/F)max of ~ 12, 
much weaker sensitivity to choline (apparent Kd 45 ± 1.1 µM) (Fig. 1c), and no detectible 
affinity for betaine nor a panel of neurotransmitters (except serotonin, which it binds with >1 
mM affinity; Supp. Fig. S4). iAChSnFR also detects the AChE inhibitors neostigmine, 
physostigmine, and rivastigmine, but not structurally divergent inhibitors such as tacrine or 
donepezil (Supp. Fig. S5a). It is actually a rather sensitive sensor for nicotine and oxotremorine 
(Supp. Fig. S5b) and differs by only a few amino acids from the simultaneously developed 
nicotine sensor, iNicSnFR36. For control experiments, we made a non-binding iAChSnFR mutant 
(iAChSnFR-NULL; mutation Tyr357Ala; no response > 100 µM ACh, choline Kd > 50 mM; 
Supp. Fig. S6). Consistent with its construction from a hyperthermophilic binding protein, 
iAChSnFR is extremely stable, unfolding at ~90°C (Supp. Fig. S7). 
 
In vitro characterization. 
Stopped-flow kinetic analysis of purified iAChSnFR shows kon = 0.62 µM-1s-1 and koff = 
0.73 s-1 (Supp. Fig. S8). pH titrations indicated an apparent pKa of 7.3 in the acetylcholine-
bound state and 9.0 in the ligand-free state (Supp. Fig. S9). Fluorescence lifetime measurements 
showed no significant differences between the apo and ligand-bound forms (Supp. Fig. S10). 
Spectroscopy showed excitation and emission similar to other GFP-based sensors (Supp. Fig. 
S11). Introducing mutations from Venus37 yielded a yellow sensor y-iAChSnFR, with two-
photon excitation compatible with 1030 nm fiber lasers (Supp. Fig. S11)38. 
 When cloned into a derivative of the pDisplay vector (Invitrogen) containing an IgG 
secretion sequence and a single transmembrane helical domain, and transiently expressed in 
HEK293 cells, iAChSnFR localizes almost exclusively to the plasma membrane, with very little 
intracellular accumulation (Fig. 1d). The sensor responded robustly to perfusion using an HBSS-
acetylcholine solution, with apparent Kd = 2.9 ± 1.6 µM, and (∆F/F)max = 10 ± 1.4 (Fig. 1c). 
 When cloned into an adeno-associated virus (AAV) vector, and expressed under the 
human Synapsin-1 promoter in cultured dissociated rat hippocampal neurons (Fig. 1e), 
iAChSnFR showed an apparent Kd of 0.4 ± 0.4 µM with (∆F/F)max = 4.5 ± 0.2 (Fig. 1c). 
 
Validation of iAChSnFR in cultured brain slices. 
We first expressed iAChSnFR in CA1 pyramidal neurons in cultured rat hippocampal slices 
with a lentiviral construct (Supp. Fig. S12a). Two-photon imaging showed iAChSnFR expression 
throughout, localized to the plasma membrane of somata, dendrites, and spines of CA1 neurons 
(Supp. Fig. S12b-c). We then expressed iAChSnFR in CA1 pyramidal neurons in cultured rat 
hippocampal slices using Sindbis virus (Supp. Fig. S13a; Methods). Epifluorescence imaging 
showed that 500-ms puffs of ACh evoked robust iAChSnFR responses, whereas puffs of artificial 
cerebrospinal fluid (aCSF) vehicle did not (Supp. Fig. S13b-d; Movie S1). As a second control, 
we expressed iAChSnFR-NULL in other hippocampal slices; no responses to ACh puff were seen 
(Supp. Fig. S13c-d). iAChSnFR also responded to oxotremorine (mAChR agonist39) and nicotine, 
with the latter exhibiting slower apparent kinetics (Supp. Fig. S13b,e-h; Movie S2). 
We next used the same preparation to study the responses of CA3 neurons by simultaneous 
imaging and patch-clamp electrophysiology (Supp. Fig. S14a). CA3 neurons express high levels 
of cholinergic receptors40 and respond robustly to ACh puffs (Supp. Fig. S14b). Patch-clamp 
recordings showed that ACh-induced inward currents rise to a peak of hundreds of pA in a few 
tens of ms, then decrease with a time constant of several hundred ms, as expected from 
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desensitization of nAChRs. Importantly, the growth of ACh-induced iAChSnFR fluorescence 
waveform matched growth of the ACh-induced currents, showing that iAChSnFR has the temporal 
resolution to reveal ACh presence as it activates nAChRs (Supp. Fig. S14d). A later phase of 
ACh-induced current grows and decays with kinetics of tens of seconds and has peak amplitudes 
of just a few pA, presumably due to mAChR activation41. Cells expressing iAChSnFR, and control, 
non-fluorescent cells nearby, showed no significant differences in their voltage-gated properties at 
rest (Supp. Fig. S14b-c). Furthermore, iAChSnFR-expressing cells showed statistically identical 
latencies from ACh puff to electrophysiological and fluorescence responses (Supp. Fig. S14d), 
indicating that iAChSnFR does not appreciably buffer ACh at this expression level and detects 
ACh as rapidly as endogenous cholinergic receptors. Notably, iAChSnFR fluorescence responses 
had a signal-to-noise ratio (SNR) > 50, at least as great as that of the ACh-induced currents (Supp. 
Fig. S14e). In response to repeated ACh puffs, iAChSnFR responses were constant, while the 
faster phase of ACh-induced currents ran down (Supp. Fig. S14f-g), as expected from many 
previous studies of nAChR desensitization41. ACh-induced currents had the same amplitude, 
latency, SNR, desensitization, rise time and decay time in iAChSnFR-expressing and control non-
expressing neurons, indicating that expressed iAChSnFR neither exerts a kinetic buffering effect 
on ACh, nor affects ACh-induced currents on its own, under these conditions. 
 
Imaging properties of cholinergic transmission in acute brain slices. 
The sensor was then expressed in acute mouse hippocampal brain slice by AAV 
transduction. In experiments with electrical stimuli on CA1 pyramidal cells, both tetrodotoxin 
(TTX) and cobalt ions (Co2+), which respectively block voltage-gated Na+ and Ca2+ channels, and 
thus vesicular transmitter release, eliminated iAChSnFR signals, confirming that the sensor is 
detecting vesicular ACh release (Supp. Fig. S15). In acute slices of medial entorhinal cortex 
(MEC, Fig. 2a)– a region rich in cholinergic projections from nucleus basalis (NB)5– iAChSnFR 
on the surface of layer 2 (L2) stellate cells responds to ACh released by electrical stimulation of 
axons of NB neurons in layer 1 (Fig. 2b). Stimuli delivered at 10-second intervals resulted in 
essentially identical waveforms with a 10-90% rise time of ~80 ms, a peak of ~10% fluorescence 
increase, and a decay time constant of ~1.9 sec (Fig. 2b,d). This demonstrates both reliable 
cholinergic transmission from basal forebrain, and reliable iAChSnFR response to release events 
at modest stimulus rates. At higher stimulus rates, time-dependent rundown of iAChSnFR signal 
occurred, providing perhaps the clearest evidence to date that in this preparation, decreased pre-
synaptic ACh release underlies the observed frequency depression in post-synaptic cholinergic 
currents42 (Fig. 2c, Movie S3). Electrical stimulus-evoked iAChSnFR signals were often restricted 
to cellular sub-regions (Movie S3). 
In awake animals, basal forebrain cholinergic neurons may alternate between tonic (~0.5-
4 Hz) or bursts of higher-frequency (~theta rhythmic) action potentials43,44. In trains of 10 stimuli 
at > 2 Hz, individual responses in slice were poorly resolved, and instead summed during the trains. 
When the train ended, fluorescence began to decay within a few sec (Fig. 2e). When 2 Hz and 20 
Hz trains were delivered alternately, the 20 Hz trains produced a higher (∆F/F)max (Fig. 2f,g). 
We next employed nanoscopic imaging and analysis algorithms45 (Methods) to visualize 
the distribution of iAChSnFR fluorescence changes on the surface of stellate cells at the micron 
scale (Fig. 2h-i, Movie S4). Electrical stimulation elicited ACh release at multiple, resolvable loci 
(Fig. 2j); release sites often clustered together, although individual release sites were sometimes 
seen. The distribution of pixel-wise relative (ΔF/F)max revealed the spatial spread of ACh after 
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release (Fig. 2k); fitting with a single exponential showed that ACh spread with a length constant 
of ~1.0 µm (Fig. 2k-l). 
Bath application of the non-competitive, reversible AChE inhibitor donepezil (Aricept®; 
does not affect iAChSnFR function, see above) increased iAChSnFR responses and slowed 
down decay kinetics resulting from electrical stimulation (Supp. Fig. S16). This indicates that 
AChE is, unsurprisingly, at least partially, responsible for terminating the observed sensor 
waveform. 
Finally, we explored cholinergic signaling onto astrocytes. ACh receptors are highly 
expressed at distal processes46, but the functional role of such receptors is poorly understood. 
First, iAChSnFR was expressed on the surface of astrocytes in acute mouse striatal brain slice 
with AAV under the glial fibrillary acidic protein (gfaABC1D) promoter (Supp. Fig. S17a,b). 
Electrical stimulation and ACh application (Supp. Fig. S17c,d,g) showed clear responses, with 
ACh puff much larger. Application of TTX ablated ACh release (Supp. Fig. S17e), whereas 
donepezil application strengthened it (Supp. Fig. S17f). Responses at somata and processes were 
similar (Supp. Fig. S17d). 
Next, we expressed iAChSnFR on astrocytes in acute MEC brain slice using lentivirus. 
Nanoscopic imaging showed prominent electrical stimulus-evoked ACh release at distal processes, 
but not somata (Fig. 2m-o, Movie S5). Single, isolated release sites were also seen on entorhinal 
astrocytes (Fig. 2o), with (ΔF/F)max ~2-fold larger than those on entorhinal neurons (Supp. Fig. 
S18). As before, an ACh spread length constant of ~1.0 µm was seen (Fig. 2p-q). Importantly, 
(ΔF/F)max of iAChSnFR-expressing neurons and astrocytes had only a weak negative correlation 
with basal fluorescence F0 (Supp. Fig. S19), suggesting that ΔF/F0 responses are largely 
independent of iAChSnFR expression levels (cf.47). 
Finally, we sought to image iAChSnFR activity while directly recording 
electrophysiological signals of cholinergic signaling in an intact circuit. For this, we co-
expressed iAChSnFR together with the G protein-coupled inwardly-rectifying potassium channel 
GIRK2 (a.k.a. Kir3.2), which couples signaling through GPCRs – including the mAChR4 (“M4”) 
expressed on striatal dorsal medium spiny neurons (dMSNs) 48 – to a distinctive K+ current, 
validated in vivo in dMSNs42,49. After successful co-transduction of dMSNs with AAV2/9-
hSynapsin1.iAChSnFR and AAV2/9-hSynapsin1.tdTomato.T2A.mGIRK2-1-A22A.WPRE.bGH, 
we directly compared iAChSnFR imaging with electrophysiological recordings in detecting 
endogenous ACh signals in acute striatal slices (Supp. Fig. S20a). In response to the same 
electrical stimulation (20-30 µA; 0.5 ms), iAChSnFR fluorescence responses had faster 
activation kinetics, but slightly slower decay, compared to presumptive M4-mediated inhibitory 
post-synaptic currents (IPSCs; Supp. Fig. S20b-g). Application of the voltage-gated Na+ channel 
blocker tetrodotoxin (TTX; 500 nM) or perfusion of Ca2+-free aCSF eliminated both iAChSnFR 
responses and M4-mediated IPSCs (p < 0.01, Wilcoxon matched-pairs signed-rank test, n = 10 
for both) (Supp. Fig. S20d,f). 
 
In vivo imaging of worm NMJ activity. 
Most NMJs in the nematode Caenorhabditis elegans signal with ACh, although some use 
GABA50. To directly image ACh function at the worm NMJ, we expressed iAChSnFR0.7 (with 
the signal sequence replaced by a worm-specific sequence; Methods) post-synaptically in body-
wall and egg-laying muscles using the muscle-specific promoter myo-3. iAChSnFR expressed 
well in both muscle types (Fig. 3a), and immobilized worms were imaged on a confocal 
microscope. We first imaged a small region of the dorsal nerve cord, where motor neurons 
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synapse onto body-wall muscles; iAChSnFR fluorescence intensity was generally higher along 
the nerve cord, relative to the muscle arms or body (Fig. 3a). We observed iAChSnFR increases 
at punctate spots reminiscent of worm presynaptic structures (Fig. 3b). In egg-laying muscles 
(vm1/2 of the vulva), iAChSnFR increases were observed at the outer muscle margins, 
presumably reflecting the sites of cholinergic innervation by VC motor neurons (Fig. 3c). 
Spontaneous iAChSnFR transients occurred with a frequency of ~0.05 Hz (Fig. 3d), similar to 
activity patterns of VC and HSN motor neurons during egg-laying behaviors51. Thus, iAChSnFR 
can read out motor neuron activity at both body-wall and egg-laying NMJs in living worms, with 
both spatial and temporal activity consistent with literature reports. 
 
In vivo detection of acetylcholine release in zebrafish. 
Zebrafish have two large Mauthner cells (one in each side of the hindbrain) that control 
the fast escape reflex52,53. Mauthner axons excite both motor neurons and inhibitory interneurons, 
ensuring that contralateral muscles relax52. Primary motor neurons in the spinal cord are known 
to receive cholinergic transmission from these cells at their ventral processes54,55. 
We established a fictive swimming preparation using an immotile zebrafish line 
(Methods). We replaced the mammalian IgG secretion sequence in iAChSnFR with the signal 
peptide from zebrafish Nodal-related 1 (Ndr1, squint). We sparsely expressed iAChSnFR in 
spinal motoneurons by microinjection of 10xUAS:iAChSnFR plasmid in a transgenic line 
expressing GAL4 under the VAChT promoter (TgBAC(vacht:GAL4)). We imaged primary 
motoneurons in spinal cord during stimulus-induced fictive escape to see cholinergic inputs to 
motoneurons including that from a Mauthner cell (Fig. 4a,b). Changes in fluorescence were 
observed in 4 cells (in 3 fish). The greatest change in fluorescence was ~7%, observed in an axon 
proximal to the soma, while other sub-cellular locations showed smaller changes (Fig. 4c,d). 
 
In vivo imaging of acetylcholine in Drosophila melanogaster. 
In flies and many other invertebrates, ACh, rather than glutamate, is the predominant 
excitatory neurotransmitter. Although the entire Drosophila melanogaster brain has been 
recently mapped to the synapse level56, the details of synaptic communication in vivo are not yet 
fully understood. Combined with myriad genetic and molecular tools already available, 
visualization of ACh in Drosophila would further facilitate mechanistic understanding of 
neuronal and circuit physiology in this model system. 
Drosophila melanogaster has about 50 glomeruli in the antennal lobe, a central brain 
structure similar to the mammalian olfactory bulb and formed by olfactory sensory neuron 
(OSN) axons, olfactory projection neuron (OPN) dendrites and local interneurons57,58. We 
replaced the mammalian IgG secretion sequence from iAChSnFR with the signal peptide from 
Drosophila immunoglobulin binding chaperone protein (BiP)59, and expressed it in OPNs under 
the GH146-GAL4 driver57. We recorded the fluorescence signal of iAChSnFR in OPN dendrites 
with two-photon excitation in whole-mount adult Drosophila, while stimulating their antennae 
with odorants. iAChSnFR reported acetylcholine release in response to individual odor trials 
(Fig. 5a) with (DF/F)max of 43% ± 4.5% (mean ± s.e.m., n = 4 flies, 6 trials per fly) with a mean 
signal-to-noise ratio of 6.88 ± 0.86. 
OPNs encode odor identity by activating different combinations of olfactory glomeruli in 
response to odorants60,61. To determine if iAChSnFR can capture the combinatorial complexity 
of odorant-induced glomerular activation, we analyzed iAChSnFR responses in 22 glomeruli to 3 
different odorants diluted to 0.1% in mineral oil: benzaldehyde (BEN), isoamyl acetate (IAA), 
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and 3-octanol (OCT). iAChSnFR had variable (DF/F)max across different glomeruli and odorants, 
ranging from -6% (BEN in VA1d) to 40% (IAA in VM3) (Fig. 5b). Rates of change were also 
variable, including a delayed response in VA1d (Fig. 5b(i), second row). Across the 22 
glomeruli, each odorant elicited a different response signature (Fig. 5b(ii)), corroborating 
previous reports from calcium indicators and electrodes61,62. 
Since varying concentrations of odorants can be represented as varied amplitudes and 
combinations of glomeruli responses, we further analyzed the iAChSnFR responses from the 22 
identified glomeruli to 2 odorants at 3 concentrations spanning 2 orders of magnitude (0.1%, 1%, 
and 10%; Fig. 5c). As with calcium imaging and electrode recordings61,63, varying odor 
concentration resulted in a wide range of iAChSnFR response amplitudes across different 
combinations of identified glomeruli. Fluorescence was positively correlated with IAA 
concentrations in some glomeruli, but negatively in others (as low as -21% below baseline, Fig. 
5c(i)). This is consistent with previous reports of OSN inhibition by certain odors64, and 
demonstrates the utility of iAChSnFR in reporting not only increases, but also decreases, in 
acetylcholine release. 
Overall, we demonstrate that iAChSnFR expressed in the Drosophila brain is both 
sensitive enough to report single-trial responses and has sufficient dynamic range to report 
complex odor coding in terms of the combinatorial code, including both excitation and 
inhibition. We believe it will be an invaluable tool in the investigation of synaptic and circuit 
dynamics in vivo. 
 
In vivo detection of acetylcholine in mouse motor cortex. 
Acetylcholine released in mammalian cortex produces biphasic responses in excitatory 
pyramidal cells (PCs) comprising fast hyperpolarization followed by slow depolarization65,66. 
This fast inhibition is mediated by both nAChRs and mAChRs, which increase the excitability 
and firing rate of PC dendrite-targeting GABAergic interneurons, primarily somatostatin (Sst)+ 
and vasoactive intestinal polypeptide (VIP)+ cells67,68. Slow depolarization is mediated by 
mAChR closure of M-type (KCNQ, a.k.a. Kv7) potassium channels in pyramidal neurons, 
enhancing their excitability5,69. Motor cortex receives active cholinergic projections originating 
from the NB70, here revealed by calcium imaging in mouse primary forelimb motor cortex (M1) 
with GCaMP6s (ref. 71; Supp. Fig. S21). Further experiments showed that direct electrical 
stimulation of NB induces a fast activation of Sst+ interneurons in layer 2/3 (L2/3) followed by 
delayed (5.5 s later) activation of pyramidal cells (Supp. Fig. S22). Thus, M1 provides a suitable 
platform for testing iAChSnFR responses in cell types responsible for biphasic cortical 
cholinergic signaling. 
To examine acetylcholine release from NB onto cortical pyramidal cells and interneurons 
(Fig. 6a), M1 of Sst-Cre mice (for interneurons) was infected with Cre-dependent AAV 
expressing iAChSnFR (AAV2/1.CAG.FLEX-iAChSnFR), and M1 of wild-type mice (for 
pyramidal cells) was infected with AAV2/1.hSynapsin1.iAChSnFR. Two weeks after AAV 
infection, Sst+ neurons showed strong fluorescence in both pyramidal cells and Sst+ neurons, with 
good membrane localization (Supp. Fig. S23a,b). Awake mice were head-restrained and 
positioned on a free-floating, linear treadmill (Methods) while iAChSnFR fluorescence was 
imaged during both quiet resting and forward running. Two-photon imaging under resting 
conditions detected fluorescence transients in subsets of layer 2/3 (L2/3) dendritic segments (Fig. 
6b-e). Fluorescence decay appeared to be faster than the upper limit of our acquisition scan 
speed (10 Hz). (ΔF/F)max of these transients was higher during running than resting (53% ± 3% 
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vs. 37% ± 2%, P < 0.001, two-way ANOVA followed by Bonferroni’s test, Fig. 6d). Local 
application of a cholinesterase inhibitor (100 µM eserine, ESR) increased (ΔF/F)max during both 
activities (Fig. 6d). 
 We next examined iAChSnFR responses on L2/3 and layer 5 (L5) PC dendrites (Fig. 
6b,e,f). In awake, quietly resting animals, we observed numerous transient cholinergic events in 
L2/3 apical tuft dendrites with (ΔF/F)max of 40 ± 2% (Fig. 6e). Forward running significantly 
increased fluorescence response (55% ± 3%, P < 0.001, two-way ANOVA followed by 
Bonferroni’s test, Fig. 6e). These responses, like those observed in Sst+ dendrites, were 
distributed across the dendritic shaft and quite focal (<0.5 µm; Fig. 6b). Responses were strongly 
modulated by electrical stimulation of NB (R2=0.33, P < 0.001, Supp. Fig. S24c) and by 
hindlimb foot shock (no shock: 45% ± 2%; foot shock: 59% ± 4%, P < 0.001, unpaired Student’s 
t-test, Supp. Fig. S24d,e). iAChSnFR signal increased with strength of NB current injection, 
from 200-800 µA, indicating a wide dynamic range of both recruitment of ACh release from NB 
fibers and of iAChSnFR response. 
Next, AAV2/1.CAG.FLEX-iAChSnFR was injected into L5 in Rbp4-Cre mice (L5-
specific)72. In Rbp4-Cre mice, iAChSnFR showed good membrane targeting in all dendritic 
compartments, including thin branches of the apical tuft, apical trunk, and basal dendrites (Supp. 
Fig. S23c). iAChSnFR fluorescence changes in response to resting and forward running were 
obvious across the dendritic arbor, even below 450 µm in basal dendrites (Fig. 6f-right). General 
anesthesia decreased peak responses (Fig. 6f-left), and eserine enhanced responses (Fig. 6e). 
Notably, iAChSnFR responses detected on both Sst+ interneurons and pyramidal cells were 
comparable to those observed with iGluSnFR23,24. 
 
Kilohertz imaging of cortical acetylcholine release. 
 Cholinergic neurons from the basal forebrain (NB) also project to visual cortex (V1), 
where ACh signaling regulates attention and visual learning73. To visualize dynamics of NB-
derived acetylcholine signals with micron spatial and millisecond temporal resolution, we used 
two-photon Scanned Line Angular Projection (SLAP) imaging38. Yellow-shifted y-iAChSnFR 
was expressed in L2/3 cortical neurons with AAV2/1.hSynapsin1.y-iAChSnFR, and an electrode 
implanted in NB (Fig. 7a). Previous work showed that 300 µm below the pia, brief stimulation 
(1 ms, 500 µA) of NB elicits punctate (<2 µm) and rapid (~10 ms) iAChSnFR transients, 
consistent with synaptic ACh release events38.  Here we compared dynamics of stimulation-
evoked ACh transients recorded from neuropil at different cortical depths in response to pulse 
trains of different lengths (1, 3, or 10 pulses at 20 Hz). Evoked neuropil transients 300 µm below 
the pia showed sharply phasic responses aligned to each stimulus, superposed on a slowly 
decaying response (Fig. 7b-bottom). This persistent component is consistent with seconds-long 
evoked transients recorded with functionalized microelectrodes74, although such methods have 
so far lacked the time resolution to detect the sharp component. Signals in superficial layers 
(<250 µm below the pia) lacked the phasic component (Fig. 7b-top), suggesting that ACh is 
degraded and/or released more slowly in superficial cortex, and demonstrating that iAChSnFR 
enables precise spatiotemporal analysis of neurotransmission (Fig. 7c). 
 
Depth-resolved recording of anesthesia effects on cholinergic signaling. 
 During anesthesia, cortical ACh levels are known to decrease75. However, due to 
limitations of existing ACh detection methodology (i.e. microdialysis), this phenomenon has 
never been explored with high spatiotemporal resolution. To directly observe ACh changes 
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during anesthesia, we injected AAV2/1.hSynapsin1.y-iAChSnFR into V1 and performed 
volumetric raster imaging (10-410 µm below pia, 12 volumes/min). y-iAChSnFR fluorescence 
across V1 decreased upon isoflurane application (Fig. 7d) and recovered following anesthesia 
removal, indicating a decrease in cholinergic tone during anesthesia, consistent with reports76. 
Superficial cortical layers showed moderate depression of iAChSnFR signal during anesthesia, 
while deeper regions showed stronger depression followed by overshoot following anesthesia 
offset (Fig. 7e,f)76. 
Cholinergic release sites and AChE expression are patterned within the cortex on scales 
from nanometers to millimeters77. iAChSnFR will help address how this patterning drives 
cholinergic signal dynamics on micron spatial and millisecond temporal scales, and how 
anesthesia affects these patterns76. 
 
Monitoring cholinergic reward signals in mouse hippocampus 
As a final demonstration of the in vivo utility of iAChSnFR, we used it to measure 
another aspect of cholinergic signaling: its contribution to reward signals78, specifically in the 
hippocampus79. Hippocampal lesions, particularly in CA1, impair acquisition and performance 
of operant (i.e. reward- and punishment-driven) tasks5. The medial septum is the source of most 
ACh released in the hippocampus, and projects multiple cholinergic fiber types to CA180. 
Accordingly, iAChSnFR was expressed in CA1 pyramidal cells by viral transduction with 
AAV2/1.hSynapsin1.iAChSnFR (Fig. 8a). First, we sought to calibrate iAChSnFR response in 
this circuit by artificially driving ACh release onto CA1 through electrical stimulation of the 
medial septum (Fig. 8a). Electrical stimulation, at several frequencies, led to robust iAChSnFR 
signals in CA1 (100 ± 24 average Z-scores above baseline, n=3 repeats at each of 4 frequencies 
in each of 4 mice; Fig. 8b). 
During behavioral testing, an increase in the fluorescence signal was observed 
immediately following reward consumption at each prescribed ratio within the progressive ratio 
operant task. The average peak intensity was 5.1 ± 0.8 (n = 26 trials) Z-scores greater than the 
average baseline signal prior to the reward event (Fig. 8c). Importantly, these increases in the 
fluorescence signal were observed in the large majority of trials (Fig. 8d). 
 
Discussion 
Here we design, optimize and exploit a genetically encoded biosensor, iAChSnFR, for 
the ubiquitous neurotransmitter acetylcholine. The sensor is based on a bacterial choline-binding 
protein, and it shows no apparent effects on neurons following stable expression in rodent brain 
slice and in living worms, fish, flies, and mice – both in the brain and at the neuromuscular 
junction (NMJ). We further created both green and yellow variants, the latter enabling kilohertz 
frame-rate imaging in mouse cortex in vivo with SLAP microscopy38. The sensor also allows 
detection of both increases and decreases of acetylcholine signaling from tonic levels. 
The new method for ACh detection is less cumbersome than previous techniques using 
microdialysis, derivatization and chromatography, or choline electrochemistry; the new method 
also has superior spatial and temporal resolution. A genetically encoded acetylcholine 
fluorescent indicator (GACh2.0)20 was recently published, based on insertion of circularly 
permuted GFP into the M3R muscarinic acetylcholine receptor. iAChSnFR constitutes an 
important complementary tool to GACh2.0 (and improved versions: GACh3.0 has about twice 
the DF/F as GACh2.0, with similar kinetics81). 
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We directly compared iAChSnFR and GACh2.0 in side-by-side in acute cortical brain 
slices. Direct sensor comparison at the same entorhinal stellate neurons shows that GACh2.0 is 
capable of detecting full cholinergic signals at a low frequency range (≤1 Hz), but not higher 
frequencies, and it fails to faithfully follow the time courses of signals at all these frequencies 
(Supp. Fig. S25a-c). Analysis confirms that iAChSnFR has several fold faster kinetics, resolving 
peak responses at ~1 Hz and summed responses at higher frequencies (Supp. Fig. S25d). (The 
soluble nature of iAChSnFR allows relevant characterization via stopped-flow experiments; 
activation has a time constant of ~ 140 ms at 10 μM ACh and just a few ms at 1 mM ACh; Supp. 
Fig. S8). iAChSnFR also showed larger (∆F/F)max than GACh2.0 (Supp. Fig. S25c,d). 
Membrane targeting of both sensors was good, across cell bodies, dendrites, and spines. 
In general, G protein-coupled receptor-based sensors and microbial periplasmic binding 
protein-based sensors have different advantages and shortcomings. GPCRs have evolved 
appropriately high affinity for measuring cognate molecules, while PBPs, which have evolved to 
help microbes navigate nutrient gradients, frequently have lower affinities. GPCRs also have 
excellent specificity relative to other endogenous molecules (in this case ACh relative to 
choline), whereas PBPs often must be tuned by protein engineering (our scaffold protein initially 
had tighter affinity for choline than ACh). However, GPCRs can be difficult to overexpress, can 
cause problems when they are21,22, and are more difficult to target to organelles than soluble 
PBPs. Furthermore, GPCRs and other receptors contain many specific 
localization/export/retention/binding sequences (e.g. endoplasmic reticulum, Golgi, membrane; 
sequences occur at the N- and C-termini and in intracellular loops) and will not necessarily 
express well in distantly related organisms. Here, we have shown that PBP-based sensors need 
no adaptation for successful function in animals as diverse as mouse, fly, fish, and worm – we 
did tailor the N-terminal secretion peptide for each organism, but this is modular and does not 
obviously affect sensor performance. 
Soluble sensors are readily amenable to purification for use in experiments such as 
vesicle fusion studies82, and also to express in the cytoplasm or organellar lumen to monitor 
transporter function83. PBPs are also readily crystallizable, which facilitates structure-guided 
optimization, and amenable to high-throughput screening as purified proteins or bacterial lysates, 
which allows the screening of thousands of mutants simultaneously. Here, we readily solved 
high-resolution crystal structures of both the full sensor and the mutated binding protein, which 
fed back into our protein design cycle, allowing us to target specific protein residues and amino 
acid mutations. 
Receptor-based sensors also recognize a host of drug molecules, precluding their 
simultaneous use with imaging. Meanwhile, PBP-based indicators have few such restrictions, 
which has allowed use of TBOA, ketamine, NBQX, and other drugs with iGluSnFR24,25,84,85, 
vigabatrin and isoflurane with iGABASnFR26, and here, tacrine, donepezil, oxotremorine and 
eserine with iAChSnFR. 
Beginning with a hyperthermophilic binding-protein scaffold was likely critical to 
successful engineering of iAChSnFR, wherein up to 8 binding-pocket residues were mutated, 
while still retaining thermodynamic stability, proper sub-cellular targeting, and large 
fluorescence responses (>10x). In addition to serving as an excellent sensor in its own right, 
iAChSnFR also provides a promising scaffold for developing additional sensors through targeted 
mutagenesis. We have developed iAChSnFR into a sensor specific for serotonin by machine 
learning-guided protein redesign and directed evolution86. In parallel with development of 
iAChSnFR, we also mutated OpuBC to recognize nicotine or the smoking-cessation drug 
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varenicline36 (PDB 6EFR). Further experiments produced variants that detect other neural drugs, 
including the rapidly acting antidepressant S-ketamine87,  selective serotonin reuptake inhibitor 
antidepressants, and opioids88. In the original OpuBC and related PBPs89, and in the better 
characterized sensors, ligand binding is mediated by cation-π interactions between the protonated 
secondary, protonated tertiary, or quaternary amine of the ligand and aromatic residues. 
 In this preliminary report describing the tool, iAChSnFR was able to illuminate a few 
biological points in various preparations. The high-resolution localization of individual ACh 
release sites with iAChSnFR lays the groundwork for the study of the fundamental features of 
acetylcholine transmission, including the transmitter diffusion extent, number of release sites, 
release pool size, release probability, quantal size and refilling rate45. 
 Even at the NMJ, where postsynaptic nAChR responses have been studied kinetically, 
pharmacologically, and computationally for decades, it has been necessary to infer the 
diffusional spread of ACh within the synaptic cleft. Simulations suggest that [ACh] reaches 
several mM for < 1 ms and that when AChE is inhibited, ACh diffusion is kinetically buffered 
by rebinding to receptors90. Because the stopped-flow kinetics (Supp. Fig. S8) show that 
iAChSnFR activation kinetics approach 100 s-1 at such concentrations, one can hope to test these 
conclusions. 
The sensor also enabled new observations about the microphysiology of transmission at 
muscarinic synapses. Previous data show that when Gi-coupled endogenous mAChRs (i.e. M2 or 
M4) on neurons or cardiac myocytes are subjected to a step of [agonist] or a decrease of 
[antagonist] on a time scale of ~1 ms, recorded GIRK channel currents show a period of zero 
slope, followed by a current that rises to a peak in a few hundred ms. This resembles responses 
after presynaptic stimulation, suggesting that coupling to Gi and activation of Gi protein effectors 
limits the time course of muscarinic transmission. iAChSnFR now enables us to compare the 
waveform of the postsynaptic response with that of pre-synaptically released ACh. Our data (e.g. 
Supp. Fig. S20d) show conclusively that ACh release is complete on a time scale of 10 ms or 
less; in fact, [ACh] has already begun to decay when the GIRK current reaches its peak. 
The microphysiological knowledge empowered by iAChSnFR also has clinical 
implications.  For example, acetylcholinesterase (AChE) inhibitor treatment, an important 
therapy for Alzheimer’s disease91, produces sub-optimal cognitive improvement and introduces 
medication termination-associated irreversible, accelerated deterioration92. The properties of 
cholinergic transmission resolvable by iAChSnFR can account for these clinical observations. 
For example, acetylcholinesterase inhibitors could cause less precise cholinergic transmission 
(cf.93), explaining the modest cognition improvement.  Moreover, long-term application of AChE 
inhibitors could lead to up-regulation of AChE levels in Alzheimer’s patients and/or down-
regulation presynaptic ACh release91, explaining the accelerated deterioration. The new insights 
into regulation and precision of cholinergic transmission not only suggests presynaptic 
cholinergic regulatory mechanisms to be effective Alzheimer’s intervention targets, but also sets 
the normal baseline for testing of candidate therapies. Likewise, analysis of cholinergic 
transmission at other cell types may shed new light on mechanisms and treatments of various 
other diseases, including diabetes94, immune deficiency95 and tumorigenesis96,97. 
The initial results at the C. elegans neuromuscular junction will allow detailed 
characterization of its release properties. Some C. elegans NMJs use GABA, for which there are 
good sensors26; together, these indicators will allow cataloguing the neurotransmitter usage and 
properties of all the components of the worm brain-muscle interface. Vertebrate NMJs use ACh 
exclusively; iAChSnFR will allow their study as well. 
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In flies, iAChSnFR showed quite large responses (up to 43% ∆F/F0 and a signal-to-noise 
ratio of 7) in olfactory glomeruli in response to odor addition. In similar experiments, GACh2.0 
showed only a 0.4% ∆F/F0 response20, although the glomeruli imaged and odors added differed 
in the two experiments. iAChSnFR also demonstrated robust negative responses to some 
glomerulus/odor combinations, demonstrating sufficient dynamic range to detect decreases in 
tonic ACh release; the utility of the GACh sensors for such bidirectional imaging has not yet 
been demonstrated. The excellent ∆F/F0 and rapid kinetics will facilitate a large number of 
experiments in flies and other arthropods, which appear to use ACh as their predominant 
excitatory neurotransmitter. 
In zebrafish, the finding that the greatest iAChSnFR signal on spinal motor neurons was 
observed at the proximal axon and the dendritic arbor makes predictions testable by forthcoming 
datasets such as the spinal wiring diagram of the larval zebrafish from serial-section electron 
microscopy98. More importantly, with the rapid growth of imaging modalities and expression 
lines for the fish, iAChSnFR enables direct visualization of cholinergic signaling in targeted cell 
types or whole-brain, which will complement results from other techniques. 
In mouse, iAChSnFR enabled a number of interesting findings. In forelimb motor cortex, 
running greatly increased iAChSnFR responses, but signals at rest were large, indicative of 
substantial tonic cholinergic signaling. iAChSnFR signals at Sst+ interneuron dendrites preceded 
those at pyramidal cell dendrites, consistent with observed biphasic ACh responses65,66. On both 
cell types, iAChSnFR signals were highly spatially localized (sub-micron), consistent with our 
results in brain slice, and supportive of a model of ACh transmission that prominently features 
fast, local, phasic signaling, perhaps also bolstered by slow, broad, volume transmission. Results 
in visual cortex, observed iAChSnFR signals were also mostly fast and sub-micron; this 
preparation enabled us to study the depth-dependence of ACh transmission properties. We found 
that deep cortical layers showed more phasic transmission aspects, whereas shallow layers 
exhibited mostly slower responses. Future experiments will explore this phenomenon more 
deeply, and elucidate the contribution of differential expression of AChE and VAChT, specific 
isoforms of ChAT, synaptic release properties, and diverse nicotinic and muscarinic receptors to 
it. 
iAChSnFR also revealed that both isoflurane and ketamine/xylazine anesthesia decreased 
cholinergic tone in the cortex. Further, we observed a depth-dependence in anesthetic effects, 
with deeper cortical layers being affected earlier and longer. The mechanism of general 
anesthesia largely remains a pharmacological mystery, although ACh is known (by 
microdialysis) to decrease in the cortex75, 76. The effects of anesthesia on ACh signaling can now 
be studied at greater spatial resolution and can be compared among anesthetics. 
Finally, our preliminary data reveal that increases in hippocampal ACh are exquisitely 
time-locked with procurement of reward during operant conditioning. These findings suggest 
that ACh release in the hippocampus accompanies adaptive effortful responding and can be 
accessed to overcome economic constraints associated with escalating costs of a commodity. 
However, further work is required to better understand the precise causal role that sub-second 
hippocampal ACh release plays in orchestrating the pursuit of reward when its associated costs 
vary as a function of response requirement. 
The spatial and temporal precision of iAChSnFR-measured ACh concentrations will 
enable neuroscience to test and to improve existing concepts such as the distinctions among 
“point-to-point transmission”, “volume transmission”, and “neuromodulation”.  It will also 
become possible to measure the detailed spatial and temporal aspects of co-release. At neurons 
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that co-release ACh and GABA, iAChSnFR and iGABASnFR signals can now be compared. 
Likewise, at neurons that co-release ACh and glutamate, iAChSnFR and iGluSnFR release can 
be compared. That synapses are exquisite biophysical machines, specialized to function on a 
time scale of milliseconds and a distance scale of micrometers, underlies the density and speed of 
information processing in nervous systems. The new biosensor, iAChSnFR, allows further 
descriptions, on the relevant time and distance scale that complement existing, primarily 
postsynaptic, electrophysiological measurements (Figs. 2, 6, S14 and S20). 
Given its broad utility in diverse organisms (in the brain and at the NMJ), excellent 
fluorescence change, kinetics, and photostability, utility alongside most cholinergic drugs, and 
apparent absence of effects on cellular function and cholinergic signaling, iAChSnFR will be a 
valuable tool for the investigation of synaptic and circuit dynamics in vivo. It is likely that further 
improvements can be made to the iAChSnFR scaffold, both in improving the performance of the 
existing green and yellow versions, and in creation of high-performance red variants. 
 
Materials & methods 
 
Sensor engineering and characterization 
The methods used to generate sensor constructs and linker variant libraries are essentially the 
same as described previously24,29. Briefly, the gene encoding OpuBC from Bacillus subtilis and 
its hyperthermophilic homologue from Thermoanaerobacter sp. X513 were ordered as gBlocks 
from IDT. These were then cloned into a modified pRSET-A vector (Invitrogen, renamed 
pHHM) using a BglII site encoding cysteine-serine at the 5’ end and a PstI site encoding leucine-
glutamine prior to the C-terminal Myc tag. Circularly permuted Superfolder-GFP was included 
in the gBlock, inserted after amino acid 83 in OpuBC and 106 in the X513 variant. Linker 
variants, binding site mutations, hinge mutations, and interface mutations were introduced by 
site-saturation mutagenesis and screened in a high-throughput manner as described 
previously24,29. Briefly, mutations were introduced using uracil template-based mutagenesis99, 
colonies were picked into deep well 96-well plates, grown overnight in auto-induction media100, 
washed 3 times with phosphate buffered saline (PBS), and frozen. Cleared lysates were then 
titrated with acetylcholine and fluorescence changes observed. Fluorescence measurements were 
acquired using a Tecan Infinite M1000 Pro plate reader, using 485 nm excitation and 515 nm 
emission settings. Detailed amino acid sequences are provided in Supplementary Fig. 3. The 
non-binding version of the sensor (iAChSnFR-NULL) was made by abolishing acetylcholine 
binding through alanine mutation of one of the key aromatic residues involved in cation-pi 
interactions (Tyr357). 
 
Protein expression and purification 
pHHM.iAChSnFR plasmids were transformed into E. coli BL21(DE3) cells (lacking pLysS). 
Protein expression was induced using liquid auto-induction medium supplemented with 100 
µg/mL ampicillin at 30°C. Proteins were purified by immobilized by Ni-NTA affinity 
chromatography in 0.1 M PBS containing 137 mM NaCl, pH 7.4. Proteins were then eluted 
using a 120 mL gradient from 0 mM to 200 mM imidazole. Following elution, fractions 
containing the sensor were pooled, concentrated using Vivaspin concentrators (Sartorius), and 
dialyzed extensively in PBS. 
 
Biochemical characterization 
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Acetylcholine, neurotransmitters, acetylcholinesterase inhibitors, choline, and glycine-betaine 
were purchased from Sigma. 200 nM of purified sensor was used for all titrations. Ligand 
binding data were fit to a single-binding site isotherm. pH titrations were performed using 
Hydrion buffers from pH 2-11 (Sigma). Circular dichroism (CD) measurements were made using 
1 µM purified sensor in 0.1X PBS using a Chirascan (Applied Photophysics) CD 
spectrophotometer. Stopped-flow analyses were performed using 200 nM sensor in PBS at room 
temperature on a SX20 LED stopped-flow instrument (Applied Photophysics) using a 490 nm 
excitation LED and 525 nm long-pass filter. 
 
Protein crystal structure determination 
iAChSnFR0.4, ligand-free structure 
iAChSnFR was expressed and purified as described above, with an additional purification step 
consisting of size exclusion chromatography. After Ni-NTA purification, the protein was loaded 
onto a Superdex 200 26/600 HiLoad column (GE Healthcare) with 5 mM MOPS, 50 mM NaCl, 
1 mM EDTA, pH 7.6 as the running buffer, and the protein was eluted at a flow rate of 2 
mL/min. Proteins were concentrated to 10-30 mg/mL for crystallization as described above. 
Crystallization was carried out at room temperature by hanging-drop vapor diffusion using 
commercially available sparse-matrix screens (Index, Hampton Research; JCSG Plus, Joint 
Center for Structural Genomics) by mixing varying ratios (1:3, 1:1, 3:1) of protein and 
precipitant solutions. From initial screens 0.05 M MgCl2, 0.1 M HEPES pH 7.5, 30% v/v 
polyethylene glycol monomethyl ether 550 (Hampton Index Reagent 55) was identified as the 
precipitant yielding the best quality crystals. Crystals were collected and shipped for data 
collection at the Advanced Light Source, Berkeley, CA on beamline 8.2.1. X-ray data were 
reduced using Mosfilm101. Structures were solved by molecular replacement using P102 and the 
CCP4 package103. Iterative cycles of model building in Coot104 and Refmac/CCP4/Phenix105 
produced the models. Final protein structures have been deposited in the Protein Data bank 
(http://www.rcsb.org). 
 
iAChSnFR, periplasmic binding protein-only 
Deletions of the N-terminal HA-tag, C-terminal Myc tag of the biosensor and GFP were carried 
out with Q5 Site-Directed Mutagenesis Kit (New England Biolabs). The plasmid encoding this 
engineered periplasmic acetylcholine-binding protein (sequence 
MHHHHHHGGAQPARSANDTVVVGSIIFTEGIIVANMVAEMIEAHTDLKVVRKLNLGGV
NVNFEAIKRGGANNGIDIYVEYTGHGLVDILGFPATTDPEGAYETVKKEYKRKWNIVWL
KPLGFNNTYTLTVKDELAKQYNLKTFSDLAKISDKLILGATMFFLEGPDGYPGLQKLYN
FKFKHTKSMDMGIRYTAIDNNEVQVIDAWATDGLLVSHKLKILEDDKAFFPPYYAAPIIR
QDVLDKHPELKDVLNKLANQISLEEMQKLNYKVDGEGQDPAKVAKEFLKEKGLILQVD
) was transformed into E. coli BL21-gold (DE3) cells (Agilent Technologies). Protein 
overexpression was carried out with ZYM-5052 autoinduction media at room temperature 
(Studier 2005). For purification, cells were lysed with four cycles of freeze-thaw in lysis buffer 
containing 100 mM NaCl, 20 mM Tris, pH 7.5, lysozyme, DNase and protease inhibitors. After 
centrifugation at 14,000 rpm for 30 min at 4°C to remove cell debris, the supernatant was 
collected and loaded onto a pre-washed NiNTA column at 4°C. NiNTA wash buffer contains 
100 mM NaCl, 20 mM Tris, 30 mM imidazole, pH 7.5, and elution was carried out with the 
same buffer containing 300 mM imidazole, pH 7.5. The eluted sample was subjected to size-
exclusion chromatography with buffer containing 100 mM NaCl and 20 mM Tris, pH 7.5 using a 
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HiLoad 16/60 Superdex 200 column (GE Healthcare). Peak fractions were pooled and 
concentrated to ~50 mg/ml with Amicon Ultra 15 concentrator (Millipore) with 10 kDa cutoff. 
Crystallization trials were carried out at 40 mg/ml in the presence and absence of 10 mM 
acetylcholine using different commercial screens. The protein crystallized in Wizard 1 
(Molecular Dimensions), condition #1, with 20% PEG 8,000, 0.1 M CHES, pH 9.5. Conditions 
was further optimized with the Additive Screen (Hampton Research), with the final mix 
containing an additional 10 mM spermidine. 
X-ray datasets were collected at Stanford Synchrotron Radiation Lightsource (SSRL) 
beamline 12-2 with a Pilatus 6M detector using a Blu-Ice interface106 The data was integrated 
with XDS107, and scaled with aimless103. Molecular replacement was carried out using Phaser in 
Phenix105 with sub-domains of iNicSnFR (PDB ID: 6EFR)36 as the input model. Subsequent 
refinement and model building cycles were carried out with phenix.refine105 and Coot104, 
respectively. 
 
Membrane anchored iAChSnFR on HEK293 cells 
For mammalian expression, iAChSnFR variants were cloned into a modified pDisplay vector 
(Invitrogen, renamed pMinDis) lacking the hemagglutinin-A (HA) tag and only retaining the 
BglII site in the multiple cloning site. pMinDis.iAChSnFR variants were transiently transfected 
into HEK293 cells (ATCC) using Amaxa electroporation and grown in high-glucose DMEM 
supplemented with 10% FBS and 2 mM glutamine in 35-mm MatTek dishes. After 1 d 
incubation at 37°C, cells were washed extensively with Hanks Balanced Salt Solution 
(Invitrogen) and imaged on a Zeiss LSM 510 inverted confocal microscope using a Zeiss 20x/0.8 
NA Plan-Apochromat objective, controlled with Zeiss Zen software. Images were acquired 
continuously at a rate of one frame per second at a resolution of 512 x 512 pixels. For 
acetylcholine titration experiments, images were collected for 1 minute at each concentration. 
The fluorescence level at each concentration was averaged over the entire minute for several 
regions of interest (ROIs) per experiment. Binding curves were fit as above. 
 
Neuronal culture characterization 
Mixed cultures of neurons and glia were prepared from Sprague-Dawley rat pups (Charles River) 
and plated on laminin-coated MatTek dishes. Three days after plating, cultures were infected 
with 1012-14 GC/mL of AAV2/1 viral particles, carrying iAChSnFR driven by the human 
Synapsin-1 promoter. One week after infection, cultures were imaged and titrated with 
acetylcholine as above. 
 
Cultured slice preparation 
Cultured slices were prepared from P6−7 rats following the previous studies47,108. In brief, 
hippocampi were dissected out in ice-cold HEPES-buffered Hanks’ solution (pH 7.35) under 
sterile conditions, sectioned into 400 µm slices on a tissue chopper, and explanted onto a 
Millicell-CM membrane (0.4-µm pore size; Millipore, MA). The membranes were then placed in 
750 µL of MEM culture medium, contained (in mM): HEPES 30, heat-inactivated horse serum 
20%, glutamine 1.4, D-glucose 16.25, NaHCO3 5, CaCl2 1, MgSO4 2, insulin 1 mg/mL, ascorbic 
acid 0.012% at pH 7.28 and osmolarity 320. Cultured slices were maintained at 35°C, in a 
humidified incubator (ambient air enriched with 5% CO2). 
 
Acute brain slice preparation 
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Acute entorhinal cortical brain slices were prepared from P25-60 animals deeply anesthetized by 
xylazine-ketamine as described in our previous reports20,108. The animals were decapitated and 
the brain block containing the entorhinal cortex or striatum was quickly removed and placed into 
cold (0−4°C) oxygenated physiological solution containing (in mM): 125 NaCl, 2.5 KCl, 1.25 
NaH2PO4, 25 NaHCO3, 1 MgCl2, 25 D-glucose, and 2 CaCl2, pH 7.4. The brain blocks were 
sectioned into 400-μm-thick brain slices using a DSK microslicer (Ted Pella Inc.). The tissue 
slices were kept at 37.0 ± 0.5 °C in oxygenated physiological solution for ~0.5−1 hour before 
imaging. During the recording and/or imaging the slices were submerged in a chamber and 
stabilized with a fine nylon net attached to a platinum ring. The recording chamber was perfused 
with oxygenated physiological solution. The half-time for the bath solution exchange was ~6 s, 
and the temperature of the bath solution was maintained at 34.0 ± 0.5 °C. All antagonists were 
bath applied. For striatal experiments, the bath solutions contained DNQX (10 μM), picrotoxin 
(100 μM), CGP55845 (300 nM), SCH 23390 hydrochloride (1 μM) and sulpiride (200 nM) to 
block AMPA, GABAA, GABAB, dopamine D1 and dopamine D2-receptors.  The bath solution 
lacking Ca2+ (Ca2+-free) was supplemented with 2 mM MgCl2.  Distinct cell types, including L2 
stellate neurons and astrocytes could be easily identified under transmitted light illumination 
based on their locations and morphology as characterized in the previous reports20,109. 
 
Sindbis and lentivirus preparation and expression 
iAChSnFR, iAChSnFR-NULL and its variants were sub-cloned into Sindbis and/or lentiviral 
constructs and viral particles were produced following our previous studies47,110. In brief, 
iAChSnFR and its variants were sub-cloned into Sindbis viral vector pSinREP5 with the cloning 
sites Xba1 and Sph1, lentiviral vector pLenti- with the cloning sites BamH1 and Xho1/Not1 
under a human synapsin promoter to ensure neuronal expression or under a GFAP promoter to 
ensure astrocyte expression. One astrocyte-targeting lentiviral construct performed best for in 
vivo expression111, and it was used in the experiments reported in Figure 2. 
 Expression of iAChSnFR, iAChSnFR-NULL or other variants was made as previously 
reported47,110. Neurons in hippocampal cultured slices were infected after 8−18 days in vitro with 
Sindbis or lentivirus, and then incubated on culture media and 5% CO2 before experiments. For 
in vivo expression, P25−60 animals were initially anesthetized by an intraperitoneal injection of 
ketamine and xylazine (10 and 2 mg/kg, respectively) or isoflurane (1-3%), and then placed in a 
stereotaxic frame. A glass pipette was used to penetrate into the entorhinal cortex or striatum 
according to stereotaxic coordinates to deliver ~50-500 nL of AAV, Sindbis or lentiviral solution 
by pressure injection to infect neurons or astrocytes with iAChSnFR. Experiments were typically 
performed within 18 ± 4 h after Sindbis viral infection or 1−2 weeks after lentiviral infection or 
3-4 weeks after infection of AAV2/9-hSynapsin1.tdTomato.T2A.mGIRK2-1-A22A.WPRE.bGH. 
 
Electrophysiology 
Simultaneous dual whole-cell recordings were obtained from two nearby infected and non-
infected hippocampal CA3 pyramidal neurons under visual guidance using fluorescence and 
transmitted light illumination47,108. The patch recording pipettes (4−7 MΩ) were filled with 
intracellular solution 120 mM potassium gluconate, 4 mM KCl, 10 mM HEPES, 4 mM MgATP, 
0.3 mM Na3GTP, 10 mM sodium phosphocreatine and 0.5% biocytin (pH 7.25) for voltage-
clamp recordings. Bath solution (29 ± 1.5ºC) contained (in mM): NaCl 119, KCl 2.5, CaCl2 4, 
MgCl2 4, NaHCO3 26, NaH2PO4 1 and glucose 11, at pH 7.4 and gassed with 5% CO2/95% O2. 
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Whole-cell recordings were made with up to two Axopatch-200B patch clamp amplifiers 
(Molecular Devices, Sunnyvale, CA). 
 
Neuronal reconstruction 
To recover the morphology of recorded neurons, the slices were fixed by immersion in 3% 
acrolein/4% paraformaldehyde in 0.1 M PBS at 4°C for 24 hours after in vitro patch-clamp 
recordings with internal solution containing additional 1% biocytin, and then processed with the 
avidin-biotin-peroxidase method to reveal cell morphology as previously reported20,110. The 
morphologically recovered cells were examined and reconstructed with the aid of a microscope 
equipped with a computerized reconstruction system Neurolucida (MicroBrightField, Colchester, 
VT). 
 
Fluorescence imaging of cells in cultured and acute slice preparations 
Wide-field epifluorescence imaging was performed using Hamamatsu ORCA FLASH4.0 camera 
(Hamamatsu Photonics, Japan), and iAChSnFR- or iAChSnFR-NULL-expressing cells in 
cultured hippocampal slices and acutely prepared brain slices are excited by a 460-nm ultrahigh-
power low-noise LED (Prizmatix, Givat-Shmuel, Israel)47,108 . The frame rate of FLASH4.0 
camera was set to 10-50 Hz. To synchronize image capture with drug perfusion, electrical 
stimulation, and/or electrophysiological recording, the camera was set to external trigger mode 
and triggered by a custom-written IGOR Pro 6 program (WaveMetrics, Lake Oswego, OR)-
based software PEPOI108. Agonists including acetylcholine, and nicotine, oxotremorine M 
(Tocris Bioscience, Bristol, UK), were puff applied with a glass pipette (~1 µm in tip diameter) 
positioned ~150 µm above the imaged neurons using 500-ms 30-kPa pressure pulses, and 
acetylcholinesterase inhibitor donepezil was bath applied.  Cholinergic fibers in tissue slices 
were stimulated with a bipolar electrode placed ~50−200 µm from imaged cells with single or a 
train of voltage pulses (500 µs, up to 50 V) to evoke ACh release. 
 Two-photon imaging was performed using a custom-built microscope operated by 
PEPOI108. The parameters of frame scan were typically set at a size of 200 × 200 pixels and a 
speed of 1 frame/s. The fluorescence of iAChSnFR was excited by a femtosecond Ti:Sapphire 
laser (Chameleon Ultra II, Coherent) at a wavelength of 950 nm. To quantify surface expression 
of GACh sensors, lentiviral expression of iAChSnFR was made in the CA1 region of 
organotypic hippocampal cultured slices. About ~1−2 weeks after expression, iAChSnFR 
expressing CA1 pyramidal neurons were patch-clamp recorded and loaded with 25 µM Alexa 
Fluor 594 (Life Technologies) for ~10 minutes, and two-photon images were then taken at 
different compartments along the somatodendritic axis. ACh-induced iAChSnFR fluorescent 
changes at the striatum were measured using 2-photon spot photometry (Toronado, B.W. 
Strowbridge), by scanning the laser around a circular path (157 nm diameter, 2 KHz) centered on 
a fluorescent punctum of interest. The green fluorescence was collected by a water immersion 
objective (60x, N.A. 1.00; Olympus), a dichroic mirror (T700LPXXR, Chroma) and filtered 
(ET680sp and ET525/50m-2P, Chroma). 
 
Nanoscopic imaging analysis 
Evoked ΔF/F0 responses of iAChSnFR expressing cells were typically imaged for periods from 
seconds to minutes.  To minimize drifting and fluctuating movements, a stable 
recording/stimulating and imaging setup was used to carry out all imaging experiments108.  
Image analysis was performed using our custom-written MATLAB-based image processing and 
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analysis program (MIPAP), with algorithms created using MATLAB 2018a with MATLAB’s 
Image Processing Toolbox (Mathworks).  After correcting photobleaching and auto fluorescence, 
all images were spatially aligned to the initial reference images using an intensity-based 
registration function to correct the minimal image drifts and fluctuations.  Then, the fluorescence 
ΔF/F0 responses at individual pixels were quantified, rescaled and converted into pseudo-color 
scales to create heatmap images.  The maximal electrically evoked maximal ΔF/F0 responses at 
individual pixels over time were subsequently plotted to create 3D spatial profiles for individual 
transmitter release sites.  To reduce other sources of noise (e.g., pixelation noise and background 
noise), super-resolution localization microscopy analysis strategies were employed to average 
over multiple exposures, multiple releases and/or multiple directions of transmitter diffusion112-
114. With these, the evoked ACh release displayed many consistent and clear nanoscopic release 
hotspots, and pixels with the maximal ΔF/F0 responses were assumed to be the centers of release.  
The average fluorescence ΔF/F0 intensity profiles normalized to the peak values fit well with a 
single exponential decay function, and the decay constants were extracted as spatial spread 
length constants.  To compensate microscopic point-spread function diffraction, we obtained our 
microscopic point-spread function with 23 nm green GATTA beads (GATTAquant GmbH, 
Hiltpoltstein, Germany). Deconvolution based on this measured point-spread function yielded 
the true spread length constants to be 0.76 µm and 0.73 µm at entorhinal stellate neurons and 
astrocytes, respectively, indicating ~35% overestimation. 
 
Slice experiments (Bonn) 
All procedures were planned and performed in accordance with the guidelines of the University 
of Bonn Medical Centre Animal-Care-Committee as well as the guidelines approved by the 
European Directive (2010/63/EU) on the protection of animals used for experimental purposes. 
All efforts were made to minimize pain and suffering and to reduce the number of animals used, 
according to the ARRIVE guidelines. Mice were housed under a 12h light–dark-cycle (light-
cycle 7 am/7pm), in a temperature (22±2°C) and humidity (55±10%) controlled environment 
with food/water ad libitum and nesting material (nestlets, Ancare, USA). Animals were allowed 
at least 1 week of acclimatization to the animal facility before surgery and singly housed after 
surgery. Juvenile C57/BL6J mice (5-7 weeks old, Charles River, Sulzfeld, Germany, male) were 
bilaterally injected with AAV2/1. hSynapsin-1.iAChSnFR following i.p. anesthesia with 
ketamine (100 mg/kg) and xylazine (16 mg/kg). Stereotaxic coordinates were 2.5, 3.0, and 3.0 
mm (posterior, lateral, dorso-ventral) relative to Bregma. Coordinates were selected to target the 
CA3/CA1 region of the ventral hippocampus. Mice were treated with analgesics (0.05 mg/kg 
buprenorphine, s.c. and 5 mg/kg ketoprofen, s.c.) and antibiotics (5 mg/kg Baytril, s.c.) 30 
minutes before the operation started.  Following anesthesia, animals were positioned in the 
stereotaxic frame, the skin and fascia were retracted to reveal the skull, and the positions were 
measured.  Small holes were drilled just through the bone, and the injection needle was slowly 
lowered to the ventral position. 1 µL of virus (undiluted, titer: 8-10 X 1012) was injected into 
each hemisphere over the course of 5 minutes. Following injection, the needle was left in place 
for 2 minutes, and then withdrawn. The scalp was sutured, and mice were left to recover on a 
heating pad until awakening from anesthesia. Mice were treated with analgesics (twice per day 
with 0.05 mg/kg buprenorphine, s.c. and once per day with 5 mg/kg ketoprofen, s.c.) and 
monitored for 3 days following surgery and then utilized in the imaging experiments 2-3 weeks 
following virus injection. Brain slices with strong expression in the stratum radiatum of CA1 
were selected for the experiment. To quantify iAChSnFR signals, a confocal scan (488nm, Zeiss 
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Pascal) was acquired in the stratum radiatum (emission band pass 514/40 nm).  The scans were 
positioned next to the stimulation pipette (glass ~1-2 MOhm resistance). During stimulation, a 
series of 30-50 frames of 512 x 128 pixels (0.41 µm pixel size) was acquired at 120 - 300 
millisecond intervals and repeated every minute.  Background-corrected DF/F per ROI was 
calculated to assess signal strength and quantify the effect of pharmacological manipulations. 
 
C. elegans methods 
We used Caenorhabditis elegans strain JSD1115 (tauEx461), derived from strain N2 by 
injection with JP992 [Pmyo-3::ss(unc-52)-iAChSnFR0.7] at 20 ng/µL and Pacr-
2::mCherry::RAB-3 at 10 ng/µL. For worm expression, the human signal sequence was replaced 
with the signal sequence from UNC-52 (perlecan, a muscle heparan sulfate proteoglycan). 
iAChSnFR0.7 was expressed in body-wall and egg-laying muscles using the myo-3 promoter. 
C. elegans were maintained on agar nematode growth media (NGM) at 20ºC and seeded 
with OP50 bacteria as previously described115. We studied young-adult (4 days after hatching) 
hermaphrodite worms. 
To image iAChSnFR fluorescence, worms were immobilized in a mixture of polystyrene 
beads and 8% agarose on a coverslip116. Images were acquired on an inverted Olympus 
microscope (IX81), using a laser scanning confocal imaging system (Olympus Fluoview FV1000 
with dual confocal scan heads) and an Olympus PlanApo 60X 1.42 NA objective. 
 
Methods for iAChSnFR imaging in astrocytes in acute brain slice 
AAV injection procedures have been described previously117. About 1 µL of 
AAV2/5.GfaABC1D.iAChSnFR (~1 x 1010 genome copies) was injected into left dorsal striatum 
or CA1 region of the hippocampus of C57BL/6NTac mice (Taconic, 8-11 weeks old, male and 
female). Imaging experiments were performed 18-19 days after the injection. Slice procedures 
have been described previously117. Coronal (hippocampus) or para-sagittal striatal slices were 
prepared. Briefly, animals were deeply anesthetized with isoflurane and decapitated. The brain 
slices (300 µm) were cut in ice-cold modified artificial cerebrospinal fluid (aCSF) containing the 
following (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl2, 26 NaHCO3, 1.2 NaH2O4, and 10 D-
glucose, saturated with 95% O2 and 5% O2. The slices were allowed to equilibrate for 30 min at 
~32 °C in normal aCSF containing (in mM): 124 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 
1.2 NaH2PO4, and 10 D-glucose saturated with 95% O2 and 5% O2. Slices were subsequently stored 
at room temperature. Slices were imaged using a confocal microscope (Fluoview 1000; Olympus) 
with 40X water-immersion objective lens with a numerical aperture (NA) of 0.8 and at a digital 
zoom of 1.5. The 488 nm line of an Argon laser was used to excite iAChSnFR. The emitted light 
pathway consisted of an emission band pass filter (505-605 nm) before a photomultiplier tube. A 
stimulus electrode (TST33A05KT, WPI) was placed at the corpus callosum. Imaging was 
performed at 10-210 µm away from the electrode. Analysis was performed at 100-200 µm away 
from the electrode. Four or eight trains (10 Hz, 0.6 mA) of electrical field stimulation (EFS) was 
applied. Images were analyzed by FIJI118. Time traces of fluorescence intensity were extracted 
from the ROIs and converted to DF/F0 values.  
 
Drosophila preparation, odor delivery, two-photon imaging and data analysis 
Ten-to-fifteen day-old adult female Drosophila melanogaster (w-; GH146/+; 20xUAS-BiP-
iAChSnFR-SV40 [VK00005]/+) were mounted on the bottom of a custom-made holder119 using 
UV-activated epoxy (Loctite 3972), with the top of the head capsule accessible from above and 
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the antennae exposed to air. An adult hemolymph-like buffer120 was loaded into the holder, then 
the cuticle and trachea above the brain were carefully dissected to allow optic access to the 
antennal lobe. 
 Pure odorants were freshly diluted with paraffin oil (Sigma-Aldrich, no. 18512) and 
stored in glass vials (BD Vacutainer, no. 366430). The odor delivery system was driven from 
pressure-regulated, filtered, compressed air and the flow rate through all lines were controlled by 
Mass Flow Controllers (Alicat Scientific). A carrier air stream of 450 standard cubic centimeters 
per minute (sccm) was directed at the antennae of the fly through the end of a syringe needle. 
The odor delivery system consists of two stages of manifolds with ultrafast miniature semi-inert 
three-way solenoid valves (The Lee Company, no. LHDA1231515H) and integrated hit-and-hold 
control circuits (Bio-Chem Fluidics Inc., no. CoolCube-50R). The first stage selects the odor to 
fill the odor line, 6 seconds before the actual stimulation; the second stage injects either the 
control air stream (50 sccm) or the odor stream (50 sccm) into the carrier air stream. Before 
stimulation, the second stage directs the control air into the carrier and the odor stream away; 
upon stimulation, the second stage directs the odor stream into the carrier and simultaneously 
directs the control air away; after 2 seconds, the second stage swaps the streams back to their 
pre-stimulation directions. After another 6 seconds, all lines are flushed with the control air 
stream for 16 seconds. The air flows through the odor delivery system continuously throughout 
the experiment and pressure never builds up in any odor vials. For each fly, a custom-written 
MATLAB (MathWorks) program controlled the structure and timing of the experiment through a 
data acquisition card (National Instruments, no. PCIe-6323). Six blocks of odor trials were 
presented to each fly. Each block includes 8 individual trials, each with either the control 
(paraffin oil) or any of the 7 odor/concentration combinations, in a randomized sequence. The 
odor/concentration pairs used are 10-3/10-2/10-1 3-octanol (OCT), 10-3/10-2/10-1 isoamyl acetate 
(IAA), and 10-3 benzaldehyde (BEN). All pure odorants are highest grade from Sigma-Aldrich. 
 Two-photon imaging was conducted on a modified Prairie Ultima Two-Photon 
Microscope (Bruker). The iAChSnFR expressed in the antennal lobes of the flies was excited 
with a Coherent Chameleon Vision II Ti:Sapphire femtosecond laser tuned to 920 nm and guided 
with one resonant galvanometer (8 kHz) along the x-axis and one non-resonant galvanometer 
along the y-axis. The emitted photons were collected with a GaAsP Photomultiplier Tube 
(Hamamatsu, no. 7422PA-40). Each imaging cycle was triggered by a TTL signal from the same 
NI-DAQ card that controlled odor delivery. The water-immersion objective (Olympus, 
LUMPlanFl/IR, 40x, 0.80 NA) was driven by a piezo so that a z-series of 4 different focal planes 
(17 µm between planes) was taken at each time point and repeated continuously until the end of 
the trial. Each plane was imaged with 2x optical zoom at 256 x 256 pixels within 16 
milliseconds. The interval between neighboring frames from the same focal plane was 150 
milliseconds, resulting in a rate of 6.7 volumes/s. 
 Image analysis was conducted after acquisition with custom ImageJ (NIH) and 
MATLAB routines. Briefly, image frames were assigned to their corresponding focal planes and 
registered with the TurboReg plug-in121. The regions corresponding to the background and 
various antennal lobe glomeruli were defined manually in ImageJ. The average pixel intensity 
within the background region and the regions of interest (ROIs) were computed for each frame. 
Olfactory response vectors were computed for each ROI after subtracting the background 
average intensity from the ROI average intensity for each time point. A Savitzky-Golay 
smoothing filter, with the polynomial order of 1 and a frame length of 3, was applied to each 
response vector for data shown in Figure 5, Panels B and C, and a frame length of 7 for Figure 5 
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Panel A. For each fly, the response vectors for the same odor-glomerulus pair over 6 repetitions 
were averaged as the mean response vector, then the normalized mean response vectors (∆F/F0 = 
(F − F0)/F0) were computed with F0 being the mean of the mean response vectors during the 2 
seconds before stimulation. The grand mean of the normalized mean response vectors and the 
standard errors of the mean (N = 4 flies) were plotted in Figure 5, Panels Bi and Ci. The 
maximum (for excitation) and minimum (for inhibition) DF/F0 for all odor-glomerulus pairs 
during the 4 seconds after stimulus onset are presented in Figure 5, Panels Bii and Cii. 
 
Zebrafish transgenic line and imaging 
All experiments were conducted in accordance with protocols approved by the Institutional 
Animal Care and Use and Institutional Biosafety Committees of the Howard Hughes Medical 
Institute, Janelia Research Campus. An immotile mutant, relaxed, was used to avoid need of the 
cholinergic blocker α-bungarotoxin for immobilization122. Relaxed fish have a homozygous loss-
of-function mutation of the dihydropyridine receptor b1 gene, Cacnb1, which couples action 
potential and contraction of muscle fibers through voltage-dependent Ca2+ release122,123. For 
expression in zebrafish, we replaced the mammalian IgG secretion sequence in iAChSnFR with 
the signal peptide from zebrafish Nodal-related 1 (Ndr1, squint). iAChSnFR was transiently 
expressed in spinal motor neurons by injecting plasmid containing 10xUAS:Ndr1peptide-
iAChSnFR into fertilized eggs from in-crosses of heterozygous relaxed, TgBAC(vacht:Gal4) 
fish. The embryos were manually removed from the chorion with a pair of forceps at 2 days post-
fertilization. By 3 days post-fertilization, immotile embryos were screened for the absence of 
tactile-induced escape behavior and for iAChSnFR fluorescence under an epifluorescence 
microscope. At 3- or 4-days post-fertilization, a screened embryo was embedded with the lateral 
side-up in 1.6% low-melting-point agar (MilliporeSigma, 2070-OP, MO). The agar covering the 
head and mid-body (from 14th to 20th segments) were removed. A brief bipolar electrical 
stimulus (1 ms in duration, 5-10 V) was delivered using a stimulus isolator (BSI-950, Dagan) 
through a concentric tungsten electrode placed on the bottom side of the head. Motor activity 
was recorded from the mid-body muscles through a glass pipette by an extracellular amplifier 
(EXT-2B, NPI). The inter-stimulus interval was longer than 1 min. The stimulus amplitude was 
adjusted to evoke strong motor activity consistently. An iAChSnFR-expressing spinal motor 
neuron was imaged with a custom two-photon microscope equipped with a resonant scanner 
(CRS 8 KHz, Cambridge Technologies) using ScanImage software (Vidrio Technologies, VA). 
Femtosecond laser pulses of 940 nm, 80 MHz (MKS Instruments, Mai Tai HP, Deep See, MA) 
were used to excite iAChSnFR. For imaging soma and neural processes at frame rate of 50 Hz 
(512 x 300 pixels), a Bessel beam was used to axially extend foci of excitation beam through an 
axicon lens module124. iAChSnFR fluorescence was detected by a photomultiplier tube (H11706-
40, Hamamatsu) through a 25x objective lens (Leica, HCX IRAPO L 25x/ 0.95 W, Germany), a 
dichroic mirror (Semrock), and emission filter (Semrock). The images were analyzed in 
MATLAB R2016b (MathWorks). Fluorescence time course of each ROI was extracted and 
changes relative to baseline fluorescence was calculated. 
 
Mouse husbandry 
All experiments were conducted in accordance with protocols approved by the Institutional 
Animal Care and Use and Institutional Biosafety Committees of the Howard Hughes Medical 
Institute, Janelia Research Campus, New York University, University of Pennsylvania, 
University of Colorado School of Medicine, University Clinic Bonn, University of California, 
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Los Angeles, University of Maryland School of Medicine, or University of Virginia School of 
Medicine. AAV experiments were conducted with wild-type C57BL/6J (Charles River), Rbp4-
Cre (MMRRC; stock no. 031125-UCD), Chat-Cre (Jackson Laboratory; stock no. 006410), and 
Sst-IRES-Cre (Jackson Laboratory; stock no. 013044), unless stated otherwise. Mice were group-
housed in temperature-controlled rooms on a 12-h light-dark cycle and were randomly assigned 
to different treatment groups. 1-to-2-month-old animals of both sexes were used for all the 
experiments. 
 
Surgical preparation for imaging awake, head-restrained mice in motor cortex 
Dendritic and somatic imaging was carried out in awake, head-restrained mice in a quiet resting 
state and forward running. Surgery preparation for awake animal imaging included attaching a 
head holder and creating a transcranial window. Specifically, mice were deeply anesthetized with 
an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (15 mg/kg) or isoflurane (5% 
for induction, 1% for maintenance). The mouse head was shaved, and the skull surface was 
exposed. The periosteal tissue over the skull surface was removed and a head holder composed 
of two parallel micro-metal bars was attached to the animal’s skull with glue (Loctite 495) to 
help restrain the animal’s head and reduce motion-induced artifacts during imaging. A small 
skull region (~0.2 mm in diameter) was located over the primary motor cortex based on 
stereotactic coordinates (at Bregma and 1.2 mm lateral from the midline) and marked with a 
pencil. This region was then thinned with a dental drill to create a thinned skull window, or a 
piece of skull was removed and a round glass coverslip (approximately the same size as the bone 
being removed) was glued to the skull. Dental acrylic cement (Lang Dental Manufacturing Co.) 
was applied to the surrounding area to secure the metal bars, taking care not to cover the thinned 
region or glass coverslip with cement. Upon awakening, mice with head mounts were habituated 
three times (10 min each time) in a custom-built imaging platform to minimize potential stress 
effects of head restraint and imaging. In this device, the animal’s head-mount was secured to 
metal blocks such that the head was fixed and perpendicular to the two-photon objective. The 
animal’s body was allowed to rest against the bottom of the solid imaging plate. Imaging 
experiments were started ~12–24 h after window implantation and free from anesthetic effects. 
 
Treadmill running under the two-photon microscope 
A free-floating treadmill was used for motor skill training in this study. This free-floating 
treadmill allows head-fixed mice to move their forelimbs freely to perform running tasks. 
Animals were positioned in a custom-made head holder device. The device enables forelimbs to 
rest on the belt and the rest of body to be positioned off-belt on a perch overlying the treadmill 
belt. During motor training, the treadmill motor (Dayton, no. 2L010) was driven by a DC power 
supply (Extech). At the onset of a trial, the motor was turned on and the belt speed transitioned 
from 0 cm s−1 to 8 cm s−1 within ~1 s. Each running trial lasted 10 s or 30 s. After completion of 
each trial, the treadmill was turned off and the next trial started after a 30 s rest period. 
 
Sensor expression and imaging in primary motor cortex 
The genetically encoded activity indicators used in this study include GCaMP6-sensitive 
(GCaMP6s) for Ca2+ imaging and iAChSnFR0.6, iAChSnFR0.6-NULL, and iAChSnFR for 
acetylcholine transient imaging. Sensors were expressed in L2/3 or L5 pyramidal neurons and 
Sst+ interneurons in M1. For L2/3 PCs, AAV2/1.hSynapsin1.GCaMP6s was used (>2 × 1013 
GC/mL titer; produced by the University of Pennsylvania Gene Therapy Program Vector Core). 
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iAChSnFR variants were expressed as AAV2/1.hSynapsin1 virus (>2 × 1013 GC/mL titer; 
produced by the Janelia virus core). For Sst+ Cre mice, GCaMP6s was expressed with AAV 
under a Cre-dependent CAG promoter (AAV2/1.CAG.FLEX-GCaMP6s; >2 × 1013 GC/mL titer; 
produced by the University of Pennsylvania Gene Therapy Program Vector Core). iAChSnFR 
variant expression in Sst+ cells and L5 PCs was accomplished with AAV2/1.CAG.FLEX virus 
(>2 × 1013 GC/mL titer; produced by the Janelia virus core). For all AAVs, 0.1 μL of virus was 
injected (Picospritzer III; 15 p.s.i., 12 ms, 0.8 Hz) into L2/3 or L5 of M1 using a glass 
microelectrode over 10–15 min. Mice were prepared for head fixation and imaging after 2 weeks 
of AAV expression. 
In Supp. Fig. S21, AAV2/1.CAG.FLEX-GCaMP6s was injected into NB based on 
stereotaxic coordinates (posterior 1 mm from Bregma and lateral 2.25 mm, at a depth of 4 mm). 
To evaluate the expression patterns of GCaMP6s axonal projections originating from NB, mice 
were fixed with 4% paraformaldehyde and the brain was sectioned at 200 μm thickness and 
immunostained against GFP (Abcam, no. ab13970, 1:300). Confocal microscopy (Zeiss LSM 
700 confocal microscope; 10× air objective, NA 0.3) revealed numerous GCaMP6+/GFP+ axonal 
projections in M1. 
 In vivo two-photon imaging was performed with an Olympus Fluoview 1000 2-photon 
system equipped with a Ti:Sapphire laser (MaiTai DeepSee, Spectra Physics) tuned to 920 nm. 
The average laser power on the sample was ~10-15 mW for L1 imaging and 15-25 mW in L2/3 
of the cortex. All experiments were performed using a 25× objective immersed in an ACSF 
solution and with 2× (somata) or 4-6× (dendrites) digital zoom. All images were acquired at 
frame rates of 2–14 Hz (2 μs pixel dwell time). Image acquisition was performed using FV10-
ASW v.2.0 software and analyzed post hoc using NIH ImageJ software. 
 
Direct NB stimulation 
In Supp. Fig. S22, mice expressing GCaMP6s in either PCs or Sst+ cells were briefly 
anesthetized with isoflurane (1%) and secured in a stereotactic frame. A small area (200 μm) of 
skull, located 1 mm posterior from Bregma and 2.25 mm lateral, was drilled such that a bone flap 
was created. The bone flap was lifted, and a parallel bipolar electrode was advanced to a depth of 
4.25 mm, at the position of the NB. Electrical stimulation was delivered at a frequency of 100 
Hz, amplitude of 500 μA, in 0.2 ms pulses for 0.5 sec. In Supp. Fig. S24, mice expressing 
iAChSnFR0.6 were also stimulated with similar parameters except varying amplitudes (200 μA 
– 800 μA). 
 
Foot shock 
Foot shocks (1 s, direct current, 0.9 mA) were delivered to the left hindpaw during recording 
trials. 
 
Motor cortex data analysis 
During quiet resting, motion-related artifacts (related to the animal’s respiration and heart beat) 
were typically less than 2 μm as detected in our cortical measurements. Vertical movements were 
infrequent and minimized by habituation, the use of two micro-metal bars attached to the 
animal’s skull by dental acrylic, and the use of a custom-built body platform. If the animal 
struggled in the body platform, imaging time points from those segments were excluded from 
quantification. All imaging stacks were registered using NIH ImageJ plug-in StackReg.  
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 Only cells expressing iAChSnFR or cytosolic GCaMP6s were included for 
quantification. Cells with apparent nuclear GCaMP6s expression71, although rare – typically at 
the center of the AAV injection site – were excluded from analysis. ROIs corresponding to 
visually identifiable somata (pyramidal cells and interneurons) were selected for quantification at 
different cortical depths from the pial surface. Imaging planes were from L2/3 and L5, 
corresponding to cells 200–300 μm below the pial surface and cells >500 μm below the pial 
surface, respectively. 
 The fluorescence time course in each cell body was measured with NIH ImageJ by 
averaging all pixels within the ROI covering the soma. The ∆F/F0 (as a percent change) was 
calculated as ∆F/F0 = (F − F0)/F0 × 100, where F0 is the baseline fluorescence signal averaged 
over a 0.5 s period corresponding to the lowest fluorescence signal over the recording period. In 
Ca2+ imaging experiments, we performed an integrated measurement of a cell’s output activity 
over 2.5 min recording, termed total integrated calcium activity, because it is difficult to report 
firing rates on the basis of calcium responses within individual cells. 
 At the depth of ~10-100 μm below the pial surface, dendrites with iAChSnFR or 
GCaMP6s expression were included for analysis. For dendritic fluorescent changes, F0 was 
background-corrected, where fluorescence background was measured from a region adjacent to 
the dendrite. Reported transients had amplitudes more than 3 times the s.d., which was on 
average ~15% ∆F/F0 for iAChSnFR and ~35% ∆F/F0 for GCaMP6s. 
 
Local in vivo drug delivery during imaging 
Tetrodotoxin (TTX) citrate (Tocris, no. 1069) and eserine (Sigma-Aldrich, no. E8375) were 
applied to the surface of M1 after removing a small bone flap (~200 μm in diameter) adjacent to 
a thinned skull window. TTX (100 nM) and eserine (100 μM) were dissolved directly in ACSF 
to final concentrations. The bone flap for drug delivery was made during awake head mounting 
and covered with a silicone elastomer such that it could be easily removed at the time of 
imaging. Because small molecules diffuse rapidly in the cortex, we estimated that the drug 
concentration was reduced ~10-fold in the imaged cortical region, such that the final effective 
concentration would be ~10 nM for TTX and ~10 μM for eserine. 
 
Visual cortex imaging during NB stimulation 
Surgery and imaging preparation was performed as in 38. Line-scan two-photon excitation was 
performed by sweeping a 156 μm long reticle focus (420 nm wide, 1.6 μm deep full width at 
half-maximum) across the sample plane at 1016 Hz. Emitted light was collected with a silicon 
photomultiplier detector (Hamamatsu MPPC). This microscope uses a 1030 nm Yb:YAG fiber 
laser for excitation (BlueCut, Menlo Sytems, 190 fs pulses, repetition rate 5 MHz). In Fig. 7, F0 
was calculated by averaging the photon count over the 300 ms prior to stimulus onset, for each 
trial. Line-scan two-photon excitation was performed by sweeping four 156 μm long reticle foci 
across the sample plane at four different angles, at 1016 Hz. The summed-intensity recorded 
from the entire image plane is reported. The effect of fluorophore bleaching was removed by 
subtracting a mono-exponential fit to the period 0-500 ms prior to and 1500-1600 ms after 
stimulus onset. A periodic heartbeat artifact was removed using a notch filter with a stopband of 
12.5-13 Hz. 
 
Visual cortex imaging during short-term anesthesia 
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Line-scan two-photon excitation was performed by sweeping four 156 μm long reticle foci 
across the sample plane at four different angles, at 1016 Hz. The summed-intensity recorded 
from the entire image plane is reported. The effect of fluorophore bleaching was removed by 
subtracting a mono-exponential fit to the period 0-500 ms prior to and 1500-1600 ms after 
stimulus onset. A periodic heartbeat artifact was removed using a notch filter with a stopband of 
12.5-13 Hz. 
 
Monitoring cholinergic reward signals in mouse hippocampus 
Animals 
ChAT-Cre+/- CB1fl/fl mice (90 days old, both male and female, Jackson Labs) were used for the in 
vivo fiber photometry experiments. All mice were single-housed in a temperature-controlled 
room on a 12-hour light/dark cycle. 
Surgery 
Mice were anesthetized using isoflurane and 500 nL of AAV2/1.hSynapsin-1.iAChSnFR 
(1.9*1012 GC/mL) was unilaterally injected in the CA1 region of the hippocampus (AP -2.2 mm, 
ML +2.0 mm, and DV −1.6 mm). Optical fibers (Thorlabs, CFMC54L02) were implanted 100 
µm above the injection site two weeks later. For the electrically stimulated recordings, the mice 
were anesthetized using isoflurane and an electrode was positioned near the medial septum (AP 
+ 0.6 mm, ML 0.0 mm, and DV −3.5 mm). While recording, the medial septum was stimulated 
with twenty 8-msec pulses at 5, 10, 15, or 20 Hz (200 µA intensity; duration 4.0, 2.0, 1.33, and 
1.0 sec, respectively) to evoke acetylcholine release in the hippocampus. Each electrical stimulus 
was supplied n = 3 times. 
Behavior 
Animals recorded during an operant task were food-restricted to 90% of body weight and food 
trained with 1 hr sessions of a fixed-ratio (FR) schedule of reinforcement. During the FR 
schedule, animals received one sucrose pellet reward for every correct press of the active lever. 
Following food training, animals were switched to a progressive-ratio (PR) schedule of 
reinforcement where to earn each incremental reward, the number of active lever presses 
required increases exponentially (5 × e(0.2 × reward number) – 5]). Each PR session ended when the 
animals failed to reach the number of active lever press required for the reward within 20 mins. 
The breakpoint, or the total number of rewards an animal received during a session, was 
considered the metric of motivation for the reward. Photometric recordings were performed 
during the duration of the PR task following 3 consecutive sessions with the same breakpoint (± 
1 reward). 
Photometry recordings 
All photometry recordings were performed using a TDT RZ5P Fiber Photometry processor, 
Doric Fluorescence minicube (FMC4_AE(405)_E(460-490)_F(500-550)_S), 2151 Femtowatt 
Silicon Photoreceiver, and TDT Synapse (2015 Edition) software. Data was analyzed using 
MATLAB (Mathworks, Edition 2018a) with the TDTMatlabSDK tool package provided by 
Tucker-Davis Technologies. 
Immunohistochemistry 
For the immunostaining, animals were anesthetized using isoflurane and perfused using 1 M 
phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA). The brains were 
removed and placed overnight in 4% PFA, washed with 1 M PBS, and cryoprotected in a 30% 
(w/v) sucrose solution. Using a cryostat, the brains were sectioned at a thickness of 40 microns. 
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The slices were incubated with DAPI for 10 mins, washed with 1 M PBS, and mounted. Images 
of the hippocampus were taken using a Leica SP8 confocal microscope. 
 
Statistical tests 
Data are presented as mean with standard error (std. err.) or standard deviation (std. dev.), as 
noted in each case. All values of n are provided; no data were excluded. For comparisons 
between two datasets, a two-sided Student’s t-test was used, unless otherwise noted. 
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Fig. 1. Sensor structure and in vitro characterization. (a) Overall iAChSnFR0.4 structure as 
determined by x-ray crystallography (PDB ID: 6URU). Orange and pink, periplasmic binding 
domain (PBP), colored to illustrate Venus-flytrap-like domain arrangement; green, circularly 
permuted superfolder GFP, with chromophore represented by spheres. Acetylcholine binding 
occurs in the cleft between the two domains of the PBP. (b) Structure of the periplasmic-binding 
protein component only from iAChSnFR (PDB ID: 6V1R), with zoom in of the binding pocket 
and residues forming cation-p interactions with acetylcholine. Aromatic residues Tyr94, Trp219, 
and Tyr243 correspond to residues labeled β, ε, and η by (ref. 34), respectively. (c) Titrations of 
purified iAChSnFR protein (soluble in vitro), and on the surface of cultured HEK293 cells and 
neurons. Data are means ± std.dev., n=3 for each experiment, fit with a sigmoidal dose-response 
curve. (d) Representative images of HEK293 cells and hippocampal neuron cultures in buffer 
alone, with 100 µM acetylcholine, and transformation of ∆F/F as a heat map. Scale bar, 200 µm. 
(e) Image of hippocampal neuron cultures infected with AAV2/1.hSynapsin1.iAChSnFR. For 
two neurons, somata are indicated by asterisks. Inset, magnification of boxed region. Plotted 
profile is the fluorescence intensity across the indicated line. Scale bars, 200 nm. 
 
  
102 103 1040.1 1 100.01
0
5
10
15
Ligand Concentration ( M)
F/
F 0
In vitro acetylcholine
In vitro choline
Non-binding NULL
Hippo neurons ACh
HEK cells ACh
a
c
b
Y94
Y243F219W
d 0 μM 100 μM ΔF/F
0 1
Relative ΔF/F
HE
K 
ce
lls
Ne
ur
on
s
*
*
e
Ligand-free/open sensor (v4) ACh-bound/closed
binding protein
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2020.02.07.939504doi: bioRxiv preprint first posted online Feb. 8, 2020; 
Fig. 2. iAChSnFR illustrates endogenous MEC cholinergic transmission.  
(a) Schematic drawing of expression and stimulation-imaging experiments acute mouse MEC 
slices. (b) Representative fluorescence responses to trains of electrical pulses at 0.5 Hz. Responses 
in the dashed boxes are expanded below. (c) Peak fluorescence responses to trains of electrical 
pulses (normalized to the first response in each train).  Red, 0.1 Hz, 5 pulses (n=13 from 12 
animals); blue, 0.2 Hz, 10 pulses (n=15 from 12 animals); orange, 0.5 Hz, 12 pulses (n=10 from 
10 animals); green, 1.0 Hz, 20 pulses (n=10 from 10 animals). Right, paired-pulse ratio for ACh 
release (peak ∆F2)/(peak ∆F1) vs. inter-stimulus interval. Dashed line indicates 100%. (d) Values 
for the 10-90% rise time and decay time constant of fluorescence waveforms for the first stimulus 
(rise time: 77±18 ms; n=11 from 10 animals; decay time constant: 1.92±0.25 s; n=11 from 4 
animals). (e-g) Analysis of pulse trains at higher stimulus frequencies. (e) Left, summation of 
fluorescence responses during trains of 10 electrical pulses at 2 (red) or 20 Hz (blue). Right, peak 
values after trains (2 Hz: 2.6±0.9%; 20 Hz: 2.5±0.7%; Z=-0.604; p=0.55; n=19 from 11 animals). 
(f) Left, fluorescence responses after two consecutive 10-pulse trains. Ten pulses at 2 Hz were 
followed, after a 5 sec pause, by a train of 10 pulses at 2 Hz (red) or 20 Hz (blue). Right, paired-
train ratio for 2+2 Hz and 2+20 Hz stimuli (2+2 Hz: 1.1±0.08; 2+20 Hz: 1.8±0.1; Z=3.296; 
p=0.001; n=14 from 10 animals). (g) Left, responses to a 10-pulse train at 20 Hz followed, after a 
5 sec pause, by a 10-pulse train at 2 Hz (red) or 20 Hz (blue). Right, paired-train ratio for 20+2 Hz 
and 20+20 Hz stimuli (20+20 Hz: 1.0±0.07; 20+2 Hz: 0.6±0.09; Z=-3.059; p=0.002; n=12 from 
10 animals). Large gray dots indicate average responses and asterisks indicate p<0.05 (Wilcoxon 
tests) in e-g. Scale bars in g apply to e-g. (h) Fluorescence snapshots for an iAChSnFR-expressing 
stellate cell responding to local electrical stimuli. (i) Temporal and spatial dependence of ΔF/F0. 
Images are Gaussian filtered to enhance visualization of release hot spots. (j) Three-dimensional 
spatial and temporal ΔF/F0 profile of the iAChSnFR-expressing cell, shown as heat map. An 
isolated release site chosen for further analysis is indicated by pink arrow. (k) Fluorescence 
responses at the isolated release site indicated by pink arrow in j at ~180 nm/pixel resolution over 
60-second imaging period creates a plot of relative maximal ΔF/F0 of each pixel against its distance 
to the pixel of largest maximal ΔF/F0. Fitting with a single exponential decay function (pink line) 
yields an estimated volume spread length constant of 1.02 µm. (l) Superimposed fits for 
exponential spread from 17 putative single release sites; the average length constant of 1.05±0.05 
µm for cholinergic transmission at MEC (n=17 sites on 8 neurons from 8 animals). (m-q) As (h-
l), for an astrocyte. In o, note that for the astrocyte, the predominant responses occur at distal 
processes, with one isolated release site indicated by pink arrow, not at the cell body (white 
asterisk). In p, fit is 1.06 µm; in q, fit is 1.04±0.08 µm (n=22 from 10 neurons from 8 animals). 
Note the average single exponential decay function fitting curves in black in l and q. 
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Fig. 3. iAChSnFR responses at the C. elegans neuro-muscular junction. (a) Longitudinal 
image of a small region of the dorsal nerve cord, where motor neurons synapse onto body-wall 
muscles; also shown are the muscle arms. (b) iAChSnFR0.7 fluorescence increases at puncta 
reminiscent of presynaptic structures (arrowheads). (c) At the vulva, egg-laying muscles (vm1/2) 
expressing iAChSnFR0.7. Region of interest (ROI) quantified in (d) indicated. (d) Fluorescence 
changes at the ROI in (c). 
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Fig. 4. Behavior-related iAChSnFR responses in larval zebrafish. (a) Schematic of 
experimental setup. (b) 2-Photon fluorescence image of iAChSnFR-expressing primary motor 
neuron in the spinal cord. (c) Magenta, trial-averaged iAChSnFR responses to electrical shock 
with fictive motor activity observed. Cyan, average of 11 waveforms without observed fictive 
motor activity. Dashed line, electrical shock. Grey, period for statistical analysis. P-values from 
n=13 (with motor activity) and 11 (without motor activity) trials, two-sample t-test shown. (d) 
Average peak iAChSnFR responses during behavior, at several somatic, dendritic, and axonal 
ROIs (n = 4 cells from 3 fish). 
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Fig. 5. iAChSnFR responses to odor stimulation in Drosophila melanogaster.  
(a) iAChSnFR can report single-trial acetylcholine release in response to odor stimulation in the 
antennal lobe olfactory projection neuron dendrites. i) Five example traces of single-trial 
responses to 10-2 3-octanol in the VC2 glomerulus. Traces show 2 sec before odor, 2 sec of odor 
stimulation (shaded), and 3 sec after odor offset. Scales for time and DF/F0 are shown at top 
right. ii) VC2 response traces from all individual trials (24 trials from 4 flies) with 10-2 3-octanol 
stimulation. Each colored line represents an individual trial. Same scales for time and DF/F0 as in 
Ai. iii) Pseudo-colored images of the right antennal lobe before and during 10-2 3-octanol 
stimulation. Each image is the average intensity projection of 8 frames (1.2 s) either before or 
during stimulation. The color scales for the fluorescence intensity are shown in the top right 
corners. Left is anterior, down is medial (“A” and “M” in the left image). The VC2 glomerulus is 
identified from the average intensity projection of all trials and shown with the white outline. 
Scale bar in the right image is 5 µm. (b) iAChSnFR reports varied acetylcholine received across 
glomeruli and time, depending on odor identity. i) Mean response traces of 3 example glomeruli 
to paraffin oil (negative control), 10-3 benzaldehyde (BEN), 10-3 isoamyl acetate (IAA), and 10-3 
3-octanol (OCT). N = 4 flies for each odorant-glomerulus combination. Gray shaded envelops 
around the traces indicate standard errors of the mean. Rectangular color shaded regions indicate 
the periods of odor stimulation. Scales for time and DF/F0 are shown at top left. ii) Heat map of 
the maximum responses across glomeruli and odorants. Positive values are for excitatory 
responses, negative for inhibitory. Color scale for DF/F0 (%) is to the right. (c) iAChSnFR 
responses demonstrate varied tuning profiles across odor concentrations and glomerulus identity. 
i) Mean response traces of 3 example glomeruli to paraffin oil (negative control) and increasing 
concentrations of isoamyl acetate (10-3, 10-2, 10-1 IAA) and 3-octanol (10-3, 10-2, 10-1 OCT). N = 
4 flies for each odorant-glomerulus combination. Gray shaded envelops around the traces 
indicate standard errors of the mean. Rectangular color shaded regions indicate the periods of 
odor stimulation. Darker shades indicate higher odor concentrations. Scales for time and DF/F0 
are shown at top left. ii) Heat map of the maximum responses across glomeruli and odor 
concentrations. Positive for excitatory responses, negative for inhibitory. Color scale for DF/F0 
(%) is to the right. 
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Fig. 5. Cont. 
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Fig. 6. iAChSnFR responses in Somatostatin interneurons and pyramidal neurons in mouse 
motor cortex.  (a) Schematic of iAChSnFR expression in different cell types within M1. (b) 
Representative 2-photon images (display inverted) of L2/3 dendrites of Sst+ neurons (top) and 
PCs (bottom). Baseline (BL) and peak signals are shown. ROIs indicated by arrowheads. Scale 
bars, 2 µm. (c)  Fluorescence traces of iAChSnFR and iAChSnFR-NULL from different ROIs 
over 12 sec trials during quiet resting, forward running (FWR), and with local application of 
eserine (ESR). (d) Average peak ∆F/F iAChSnFR signals from Sst+ apical dendrites during 
resting and forward running (rest: 37 ± 2%, n = 72; run: 53 ± 3%, n = 63; P < 0.001, t=4.08, 
df=215), and with local ESR (rest: 58 ± 3%, n = 49, P < 0.001, t=5.11, df=215; run: 61 ± 4%, n = 
35, P < 0.001; t=5.31, df=215). (e) Average peak iAChSnFR signals from PC apical dendrites 
during quiet resting and FWR (rest: 40 ± 2%, n = 86; run: 55 ± 3%, n = 58). iAChSnFR-NULL 
showed minimal signals (rest: 8 ± 1%, n = 75, P < 0.001, t=18.3, df=269; run: 10 ± 1%, n = 73, 
P < 0.001, t=17.2, df=269). TTX addition greatly lowered signals (rest: 19 ± 2%, n = 24, P < 
0.001, t=6.63, df=165; run: 23 ± 2%, n = 20, P < 0.001, t=5.21, df=165). ESR addition enhanced 
signals during FWR but not resting (rest: 44 ± 3%, n = 74, P = 0.82, t=1.09, df=305; run: 65 ± 
3%, n = 91, P < 0.001, t=7.03, df=305). (f) Average peak iAChSnFR signals from apical tuft 
dendrites (rest: 47 ± 3%, n = 78; run: 56 ± 3%, n = 58, P < 0.03, t=2.22, df=134) and basal 
dendrites (rest: 34 ± 4%, n = 22; run: 48 ± 4%, n = 21, P < 0.02, t=2.33, df=41) of L5 PCs. 
Anesthesia with 1% isoflurane (29 ± 3%, n = 31, P < 0.02, t=2.58, df=158) and 
ketamine/xylazine (KX) (29 ± 2%, n = 44, P < 0.01, t=2.89, df=158) weakened iAChSnFR 
signals. Data are presented as means ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, unpaired 
Student’s t-test in f (basal dendrites) and two-way ANOVA followed by Bonferroni’s test in d-f 
(apical dendrites). Representative images and traces from experiments carried out on at least 3 
animals per group. 
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Fig. 7. Depth-resolved responses to electrical stimulation of nucleus basalis and anaesthesia. 
(a-c) Depth-dependent y-iAChSnFR responses to electrical stimulation of nucleus basalis (NB). 
(a) Experimental schematic. Visual cortex was densely labeled with AAV2/1.hSynapsin1.y-
iAChSnFR. y-iAChSnFR signals were recorded from ~100 µm x 100 µm of neuropil at defined 
depths using SLAP 2-photon imaging, while electrically stimulating NB. (b) Example neuropil 
responses to trains of 1, 3, and 10 stimuli, 10 µm (top) and 300 µm (bottom) below pia. 
Arrowheads mark time of stimuli. (c) Response amplitudes averaged for the period between 500 
and 1000 ms following onset of stimulation. Stimuli consisted of 1 ms, 500 µA pulses at 20 Hz. 
Mean of n=20 trials per condition. (d-f) Depth-resolved response of y-iAChSnFR to transient 
anaesthesia. (d) Example image plane (380 µm depth) before, during, and shortly after transient 
anaesthesia. (e) Average y-iAChSnFR intensity in a 156 x 156 x 400 µm deep region of visual 
cortex, at each Z-plane. 1.5% isoflurane anaesthesia applied from 16 to 32 min. Intensity was 
normalized to the mean during the waking period, per plane. (f) Normalized intensity of the most 
superficial (top) and deepest (bottom) 100 µm regions (20-110 µm, 310-400 µm below pia). 
Shaded region denotes period of anaesthesia. N = 4 sessions shown in gray traces; black trace is 
mean. *: Mean response for this period differed from awake (“pre”); ↕*: Mean response for this 
period varied with depth, p<0.05, paired two-sample Student’s t-test. 
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Fig. 8. Monitoring hippocampal reward related ACh transmission in vivo during an 
operant task. a) Schematic of the experiment. eStim, electrical stimulation in the medial septum. 
F.P., fiber photometry in hippocampal CA1 region. b) Response to electrical stimulation. 
Representative individual Z-scores of iAChSnFR signals following electrical stimulation (twenty 
8-msec pulses of 200 µA intensity at 5, 10, 15, or 20 Hz, for 4.0, 2.0, 1.33, and 1.0 sec, 
respectively) in the medial septum (n=3 repeats at each frequency in each of 4 mice). Mean of all 
responses (dark blue; average of every repeat of every stimulus frequency in every mouse) Z-
score ± s.e.m. (light blue shading). c) Mean Z-score ± s.e.m. during a progressive ratio operant 
task (n=26 trials in a single, representative mouse). d) Heatmap illustration of Z-scores on each 
trial during the operant task. 
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Supplementary Fig. S1.  Sequence analysis of the various PBP sequences used in this study.  (a) 
Phylogenic tree relating the four sequences. Numbers represent branch length. (b) ClustalW 
alignment of the four sequences.  The four key aromatic residues (Tyr94, Trp219, and Tyr243) 
involved in cation-pi interactions are highlighted in magenta boxes; the last three correspond to 
residues labeled g, ε, and η in ref. 34, respectively. Sm = Sinorhizobium meliloti, Bs = Bacillus 
subtilis, TsX513 = Thermoanaerobacter sp. X513. 
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Supplementary Fig. S2. Isothermal titration calorimetry analysis of Thermoanaerobacter sp. 
X513 OpuBC homologue.  (Top) 100 µM purified protein was titrated with 1 mM ACh at 25°C 
in PBS. Curve fitting with a fixed stoichiometry (N) of 1 yields a calculated Kd for ACh of 95 
µM (red curve; Chi2 for fit = 1300). Curve fitting with a variable N yields a calculated Kd of 65 
µM with N=1.22 (not shown). (Bottom) 80 µM purified protein was titrated with 1.5 mM choline 
at 25°C in PBS.  Curve fitting with variable stoichiometry yields a calculated Kd of 8 µM and a 
stoichiometry of 0.55 (red curve; Chi2 for fit = 9300). Each experiment was performed once. 
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Supplementary Fig. S3.  Annotated amino acid sequence of iAChSnFR and variants. Insertion 
of cpSFGFP is after residue E106 of X513. Residues RS near the N-terminus encode a BglII 
restriction site, and residues LQ at the C-terminus encode a PstI restriction site. Domains 
colored. Amino acid numbering matches normal N-to-C numbering of each domain. X513 
OpuBC starts at 30 (the first 29 amino acids are an endogenous secretion signal, which is 
omitted). cpSFGFP is numbered from 147-238.GGTGGS.1-146; the chromophore (TYG) is 
numbered 65-67. 
 
Binding site mutations: K39I, T72V, E174F, R178G, F219W 
Peripheral binding site mutations: N40I, Q44G, T97H 
Hinge mutations: A143T, D273L 
Proto-interface mutations: K113G, D124R, V188L, H238A 
X513-cpSFGFP linker-1 mutations: M105F, E106P, S147E (cpSFGFP), H148P (cpSFGFP) 
cpSFGFP-X513 linker-2 mutations: N146P (cpSFGFP), +PP insertion, P107A 
 
Mutations in earlier versions of iAChSnFR: 
0.4: K39I M105F E106P GFP-S147E GFP-H148P GFP-N146P +PP R178K 
0.6: 0.4+ N40I P107G K113G D124R E174F R178K V188L H238A D273L V283R 
0.7: 0.6+ N40E Q44G T72E T97H P107S T108S R178G V283V 
iAChSnFR: 0.7+ N40I T72V T97H P107A T108T A143T F219W 
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Supplementary Fig. S4.  Top, responses of iAChSnFR to other known and putative 
neurotransmitters; 200 nM iAChSnFR was titrated with various concentrations of the ligands 
tested.  Bottom, tests of the effects of ligands on the response of iAChSnFR to ACh; 200 nM 
iAChSnFR was titrated with acetylcholine in the presence of 1 mM of each of the ligands listed. 
Mean of n=3 technical replicates, error bars show std.dev. 
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Supplementary Fig. S5.  a) Influence of acetylcholinesterase inhibitors on iAChSnFR.  200 nM 
iAChSnFR0.7 was titrated with various concentrations of acetylcholine in the presence of 50 µM 
of each of the acetylcholinesterase inhibitors listed. Mean of n=3 technical replicates, error bars 
show S.D. b) Affinity of iAChSnFR for the nAChR and mAChR agonists nicotine and 
oxotremorine, respectively. 200 nM iAChSnFR was titrated with various concentrations of each 
compound. Mean of n=3 technical replicates, error bars are std.dev. 
 
a)                                                                          b) 
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Supplementary Fig. S6. Responses of iAChSnFR and the NULL variant to acetylcholine or 
choline. 200 nM iAChSnFR was titrated with various concentrations of the two compounds. 
Mean of n = 3 technical replicates, error bars are s.e.m. 
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Supplementary Fig. S7.  Circular dichroism (CD) measurements of iAChSnFR.  Top, 1 µM of 
iAChSnFR was thermally denatured in 0.1X PBS.  Note that the upper temperature limit for the 
instrument used is 95°C.  Bottom, plot of CD signal at 222 nm as a function of temperature. 
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Supplementary Fig. S8.  Stopped-flow kinetic analysis of iAChSnFR.  Top, 200 nM iAChSnFR 
was mixed with varying concentrations of acetylcholine at 25⁰C to produce the indicated final 
[ACh] values. Bottom, kobs plot as a function of concentration; left panel, linear fit of the data at 
≤ 10 μM. Fitted kinetic parameters: kon = 0.62 µM-1s-1, koff = 0.73 s-1, apparent Kd (stopped-flow) 
= koff /kon = 1.2 µM. Mean of n = 3 technical replicates, error bars show s.e.m. 
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Supplementary Fig. S9.  pH titrations of iAChSnFR.  Top, fluorescence of the acetylcholine-
saturated (open circles, 100 µM acetylcholine) and -free (circles) normalized to peak 
fluorescence of iAChSnFR0.7.  Bottom, measurement of ∆F/F0 as a function of pH.  
Measurements were made using 200 nM sensor, in colorless Hydrion buffers. Mean of n=3 
technical replicates, error bars show std.dev. 
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Supplementary Fig. S10.  Fluorescence lifetime characterization of iAChSnFR. Two-photon 
fluorescence lifetime measurement of iAChSnFR in both apo and acetylcholine-saturated states.  
Single exponential curve fits show a lifetime of 2.59 nanoseconds for the apo form and 2.58 
nanoseconds for the acetylcholine-bound form. Lifetime measurements were taken at 950 nm 
excitation wavelength at 10 mW power with a neutral density (ND 0.5) filter placed in the 
excitation path. 
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Supplementary Fig. S11.  Top. One-photon fluorescence spectra of iAChSnFR and y-
iAChSnFR.  a) iAChSnFR: Excitation (5 nm bandwidth) was measured at an emission 
wavelength of 650 nm/20 nm bandwidth; emission (5 nm bandwidth) was measured at excitation 
wavelength of 485 nm/2.5 nm bandwidth, with 1 µM iAChSnFR in PBS + 1 mM acetylcholine 
(solid traces) or PBS alone (dashed traces).  b) y-iAChSnFR: Excitation (5 nm bandwidth) was 
measured at an emission wavelength of 555 nm (5 nm bandwidth); emission (5 nm bandwidth) 
was measured at excitation of 470 nm/5 nm bandwidth, with 1 µM iAChSnFR in PBS + 10 mM 
acetylcholine (solid traces) or PBS alone (dashed traces). Middle. Two-photon peak brightness 
spectra, along with calculated ∆F/F at each wavelength. 2P spectra obtained at 1 mW power 
across 720-1080 nm, fluorescence collected with a 550BP88 filter. c) iAChSnFR: apo (dashed) 
and acetylcholine-bound (solid) sensor. d)  y-iAChSnFR: apo (dashed) and ACh-bound (solid) 
sensor. (e) Titration of y-iAChSnFR with ACh (black, Kd = 500 nM) and choline (gray, Kd = 20 
µM). Mean of n=3 technical replicates, error bars show std.dev. 
 
 
 
 
 
 
 
 
 
 
  
c) d) 
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Supplementary Fig. S12.  iAChSnFR displays well on the membrane of CA1 neurons in brain 
slice.  (a) Two-photon montage of images (green, EGFP channel; red, AlexaFluor 594 channel) of 
an iAChSnFR-expressing CA1 neuron pipette-loaded with 5 µM AlexaFluor 594. Slice thickness 
is 400 µm. (b) Representative two-photon images of: top) a dendrite and spine, middle) the 
dendrite 50 µm away from the soma, and bottom) the soma of another iAChSnFR-expressing CA1 
neuron. Also shown are the sites of line scans for quantification in (c). (c) Means and std. err. of 
normalized green and red fluorescence measured from line scans across somata (n = 14 from 14 
neurons of 12 animals), dendrites ~50 µm away from the soma (n = 17 from 17 neurons of 12 
animals), and spines (n = 25 from 15 neurons of 12 animals) of iAChSnFR-expressing CA1 
neurons. 
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Supplementary Fig. S13.  Response of iAChSnFR in hippocampal CA1 slice to puffs of 
ACh. (a) Schematic of the experiments. (b) Snapshots of fluorescence images (upper) and 
relative fluorescence responses in heat map format (lower) of iAChSnFR-expressing CA1 
neurons to a 500-ms puff of ACh (1 mM, left) or nicotine (1 mM, right). (c) Fluorescence 
responses (offset vertically, all have same baseline) of iAChSnFR and iAChSnFR-NULL to a 
500-ms puff of ACSF or 1 mM acetylcholine (ACh). (d) Values for fluorescence responses from 
(c) (ACh: 6.4±0.2%, ACSF: 0.2±0.02%, Z=3.7, p<0.001 for iAChSnFR; ACh: 0.3±0.06%, 
ACSF: 0.1±0.02%, Z=3.0, p<0.005 for iAChSnFR-NULL; n=18 from 5 animals). (e) 
Waveforms of fluorescence responses of iAChSnFR to a 500-ms puff of ACSF, 1 mM 
oxotremorine (Oxo), 1 mM nicotine (Nic) or 1 mM ACh. (f, g, h) Analysis of waveforms in e. (f) 
Peak fluorescence response (Oxo: 3.6±0.6%, Z=3.1, p<0.005; Nic: 5.2±0.6%, Z=3.1, p<0.005; 
ACh: 3.5±0.3%, Z=3.6, p<0.005; ACSF: 0.2±0.02%, n=12 from 5 animals). (g) 10-90% rise 
time (Nic: 4.6±0.5 s, Z=2.8, p<0.01; Oxo: 2.2±0.2 s, Z=-1.1, p=0.26; ACh: 2.4±0.2 s, n=12 from 
5 animals). (h) Decay time constant (tau; Nic: 27.0±2.0 s, Z=2.8, p<0.01; Oxo: 12.6±1.8 s, Z=-
2.1, p<0.05; ACh: 8.4±1.1 s, n=12 from 5 animals).  Large gray dots indicate average 
parameters; asterisks indicate p<0.05 (Wilcoxon rank-sum test). 
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Supplementary Fig. S14.  Expression of iAChSnFR does not detectably affect ACh-induced 
currents in hippocampal CA3 slices. 
(a) Schematic of simultaneous imaging and electrophysiological recording experiments. 
(b) Left, simultaneous fluorescence and current responses of a pair of neighboring CA3 neurons. 
The neuron at left is fluorescent, showing that it expresses iAChSnFR; the neuron at right is non-
fluorescent (showing that it does not express iAChSnFR and serves as a control). A 500-ms puff 
application of 1 mM ACh was applied.  Right, the responses in the left dashed box are replotted 
in an expanded time scale.  Note that both the fluorescence and current waveforms begin with 
latencies < 300 ms, and that ACh-induced currents appeared to consist of fast and slow 
components, corresponding presumably to nicotinic and muscarinic currents. 
(c) Values for peak ACh-induced fluorescence (iAChSnFR: 4.0±0.6%; Ctrl: 0.1 ± 0.02%; Z=2.8; 
p=0.005), and for peak ACh-induced currents in iAChSnFR-expressing neurons compared to 
non-expressing neurons, for fast (iAChSnFR: 67.2±15.0 pA; Ctrl: 63.5±9.5  pA; Z=0.5; p=0.59) 
and slow (iAChSnFR: 26.2±9.2 pA; Ctrl: 19.2±4.0 pA; Z=0.8; p=0.44) currents (n=10 neuron 
pairs from 5 animals). 
(d) Latencies of ACh-induced currents in iAChSnFR-expressing (iAChSnFR: 411.7±46.3 ms; 
Z=-0.1; p=0.92) and non-expressing CA3 neurons (Ctrl: 418.9±43.5 ms; Z=0.7; p=0.48) 
compared to those of fluorescence responses of iAChSnFR-expressing neurons (iAChSnFR: 
416.7±50.0 ms) (n=9 neuron pairs from 4 animals). 
(e) Values for the signal-to-noise ratio (SNR) of cholinergic fluorescence responses of 
iAChSnFR expressing CA3 neurons compared to non-expressing neurons (iAChSnFR: 56.3±9.1; 
Ctrl: 1.5±0.3; Z=-2.7; p=0.008), and that of fast (iAChSnFR: 23.2±4.6; Ctrl: 25.2±4.7; Z=-0.06; 
p=0.95) and slow (iAChSnFR: 8.2±2.1; Ctrl: 9.0±3.5; Z=-0.2; p=0.86) cholinergic current 
responses of iAChSnFR-expressing CA3 neurons compared to non-expressing neurons (n=9 
neuron pairs from 4 animals).  Note that SNR of cholinergic fluorescence responses of 
iAChSnFR-expressing CA3 neurons is larger than both fast (iAChSnFR: Z=-2.7; p=0.008; Ctrl: 
Z=-2.2; p=0.028) and slow (iAChSnFR: Z=-2.7; p=0.008; Ctrl: Z=-2.2; p=0.028) cholinergic 
current responses of iAChSnFR-expressing and non-expressing CA3 neurons. 
(f-g) ACh-induced fluorescence displays less rundown than ACh-induced currents.  
(f) Values for the two consecutive fluorescence responses of iAChSnFR-expressing (1st: 
0.08±0.01%; 2nd: 0.08±0.02%; Z=-0.1; p=0.88) CA3 neurons (n=13 neuron pairs from 5 
animals). 
(g) Peak responses for two consecutive fast cholinergic current responses in iAChSnFR-
expressing (1st: 68.2±12.1 pA; 2nd: 34.1±4.7 pA; Z=-2.5; p=0.011) and control non-expressing 
(1st: 64.7±7.8 pA; 2nd: 48.0±3.9 pA; Z=-2.0; p=0.49) CA3 neurons, and values for the two 
consecutive slow cholinergic current responses of iAChSnFR-expressing (1st: 26.0±7.4 pA; 2nd: 
16.6±2.8 pA; Z=-0.5; p=0.59) and control non-expressing (1st: 20.4±3.4 pA; 2nd: 16.3±4.8 pA; 
Z=-0.9; p=0.37) CA3 neurons (n=9 neuron pairs from 4 animals).  Large gray dots indicate 
average responses and asterisks indicate p<0.05 (Wilcoxon rank-sum tests). 
Data for panels c – g are for n=15 cells from 8 animals. 
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Supplementary Fig. S14.  Cont. 
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Supplementary Fig. S15.  iAChSnFR detects electrically evoked ACh release from 
presynaptic sites in hippocampal slices. 
(a) Representative confocal scan of iAChSnFR expression in the CA1 area of an acute 
hippocampal slice (top panel, mouse 12 weeks). The stimulus was applied from a glass pipette 
electrode placed in hippocampal CA1 stratum radiatum (2 x 100 µs stimuli, 100 ms interval). 
The middle panel shows a difference image calculated between the peak and the pre-stimulus 
fluorescence (after and before the asterisk shown in b)). Note the punctate appearance of the 
fluorescence increases (DF), mostly in stratum radiatum. Lower panel shows an overlay of DF 
and the resting fluorescence shown in the top panel and illustrates that responding puncta 
localize to structures in the neuropil. Scale bars: 50 µm. 
(b) Exemplar fluorescence waveform for the dashed ROI shown in a). Asterisk indicates the time 
of stimulation. The average DF/F was 0.24 ± 0.02 (n = 13 from 3 animals). Red trace shows fit to 
a single exponential. 
(c) Left, 10-90% rise time (0.7 ± 0.06 s) and right, average decay time constant (3.0 ± 0.3 s) 
obtained by mono-exponential fitting (n = 13). 
(d) Left, exemplar waveforms of iAChSnFR response before and after 1 µM TTX application 
(DF peak: average of 4 successive points, red), demonstrating that the responses depend on 
presynaptic action potential generation. Right, peak DF difference image, for control and +TTX. 
Scale bars: 50 µm. 
(e) Left panel: representative traces before and after 1 mM CoCl2 application to block 
presynaptic Ca2+ entry required for action potential-dependent ACh release. Right panel: time 
course of the peak of electrically evoked responses showing their reproducibility, stability and 
responsiveness to the block of Ca2+ entry. 
(f) Summary bar graphs (% of control) of the inhibitory effect of TTX (8.4 ± 4.9%; n = 4) and 
cobalt (14.6 ± 1.6%; n = 3) on electrically evoked iAChSnFR responses. Error bars show std.err. 
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Supplementary Fig. S16. iAChSnFR illustrates the role of AChE in restricting cholinergic 
transmission. 
(a) Fluorescence waveforms of iAChSnFR-expressing MEC neurons to a single electrical pulse 
followed by a train of 20 pulses at 2 Hz in normal ACSF with or without 0.5 μM donepezil. 
(b) Peak fluorescence responses to single pulses (Ctrl: 0.6±0.07%; Exp: 0.8±0.06%; Z=2.380; 
p=0.017; n=8 from 8 animals) and 20 pulses (Ctrl: 2.0±0.4%; Exp: 2.8±0.5%; Z=2.599; p=0.009; 
n=10 from 10 animals) in ACSF with or without 0.5 μM donepezil. 
(c) The 10-90% rise time of fluorescence responses waveforms for single pulses (Ctrl: 0.2±0.04 
ms; Exp: 0.8±0.4 s; Z=1.512; p=0.128; n=7 from 7 animals) and 20 pulses (Ctrl: 5.7±0.9 s; Exp: 
7.9±1.1 s; Z=2.497; p=0.013; n=10 from 10 animals) in ACSF with or without 0.5 μM donepezil. 
(d) The decay time constant of fluorescence responses waveforms for single pulses (Ctrl: 2.2±0.5 
s; Exp: 3.3±0.7 s; Z=2.203; p=0.043; n=7 from 7 animals) and 20 electrical pulses (Ctrl: 4.7±0.7 
s; Exp: 10.1±1.2 s; Z=2.666; p=0.008; n=9 from 9 animals) in ACSF with or without 0.5 μM 
donepezil.  Large gray dots indicate average responses and asterisks indicate p<0.05 (Wilcoxon 
tests). 
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Supplementary Fig. S17.  Hippocampal astrocyte expression and responses. (a) Schematic 
illustrates the protocol of astrocyte cell-surface ACh imaging using iAChSnFR. (b) 
Immunohistochemical analysis shows astrocytic expression of iAChSnFR. iAChSnFR was 
expressed in S100β-positive cells (astrocytes) but not NeuN-positive cells (neurons). (c) 
Representative images of iAChSnFR before (control), during (ACh) and after (wash) application 
of ACh. The images are shown on an arbitrary "fire" color scale from 0 (black) to 256 (white), 
with warmer colors indicating higher fluorescence. (d) Averaged traces of iAChSnFR signals 
from soma and processes. (e) Electrically evoked ACh increases on striatal astrocytes. Grey 
traces indicate individual traces. Red traces indicate averaged traces. Evoked signals were 
abolished by TTX (control, 0.12 ± 0.01; TTX, 0.03 ± 0.03, t(23) = 3.93, p < 0.001, n = 24, paired 
Student’s t-test). (f) Evoked ACh increases were enhanced by donepezil, an AChE inhibitor 
(control, 0.09 ± 0.02; donepezil, 0.18 ± 0.02, t(11) = 2.35, p<0.05, n = 12, paired Student’s t-
test). (g) Bath application of ACh induced robust iAChSnFR signals on striatal astrocytes. 
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Supplementary Fig. S18. iAChSnFR detects especially large signals at single release sites 
near entorhinal astrocytes. (a) Schematic drawing of stimulation-imaging experiments on 
entorhinal neurons and astrocytes in acute mouse MEC slices. HP: hippocampus.  (b) Values for 
peak ΔF/F0 responses at single release sites of entorhinal neurons (e.g., see Fig. 2j) and astrocytes 
(e.g., see Fig. 2o) (Neuron: 17.6±1.5%, n=13 from 6 neurons from 6 animals; Astrocyte: 
38.4±5.9%, n=22 from 10 neurons from 8 animals; U=216.0, p=0.013). Large gray dots indicate 
average responses and asterisk indicates p<0.05 (Mann-Whitney rank-sum non-parametric test). 
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Supplementary Fig. S19.  iAChSnFR provides useful data over a wide range of expression 
levels. (a) Analysis on the sub-µm scale. A snapshot of the iAChSnFR-expressing MEC stellate 
neuron shown in Figure 2h-k (image is 123 x 166 pixels, 0.181 µm/pixel). (b) Scatter plot of ΔF/F0 
against F0 of the neuron in (a) at each pixel (20,418 pixels in the ROI). The data show a weak 
negative correlation between ΔF/F0 and F0 with a slope value of -0.00014 (n = 20,418; normality 
test p = 0.001; constant variance test p = 0.001; r2 = 0.047; F = 1,004.46; p < 0.001; linear 
regression t test).  (c) Analysis on the µm scale. A snapshot of the iAChSnFR-expressing MEC 
astrocyte shown in Figure 2m-p (image is 694 x 331 pixels, 0.181 µm/pixel).  (d) Scatter plot of 
ΔF/F0 against F0 of the astrocyte in (c) at each pixel (229,714 pixels in the ROI). a weak negative 
correlation between ΔF/F0 and F0 with a slope value of -0.000703 (n = 65,536; normality test p < 
0.001; Constant variance test p < 0.001; r2 = 0.0507; F = 12,257.27; p < 0.001; linear regression 
t-test). 
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Supplementary Fig. S20.  iAChSnFR signals precede ACh-mediated potassium currents in 
the striatum. (a) Schematic illustration of the procedure. (b) 2-photon iAChSnFR fluorescence 
image in a slice from dorsal striatum.  Arrow shows location of iAChSnFR hotspot illustrated in 
panel c. (c) 2-photon excitation and spot photometry fluorescence waveform for electrical 
stimulation (30 µA; 0.5 ms). Green trace is the average of 13 sweeps.  Single trial fluorescence 
responses in gray. (d) 2-photon excitation and spot photometry fluorescence waveform (average 
40 sweeps), compared with a presumptive muscarinic acetylcholine receptor M4-mediated 
inhibitory post-synaptic current (IPSC) from a dorsal medium spiny neuron (dMSN; average 5 
sweeps). (e) 2-photon fluorescence image of iAChSnFR in the dorsal striatum. Arrow indicates 
location of iAChSnFR hotspot illustrated in panel d. (f) Peak amplitude of fluorescence 
waveforms (∆F/F %) and M4-IPSC amplitude (pA) under control conditions and in the presence 
of TTX (1 µM) and Ca2+- free ACSF (n = 10). **: p <0.01, Wilcoxon matched-pairs signed-rank 
test. (g) Summary of fluorescence waveforms and M4-IPSC waveforms. Activation kinetics for 
iAChSnFR (10-90% rise time = 37.2 ± 4.8 ms, time to peak = 92.9 ± 7.5 ms; M4-mediated 
IPSCs: 10-90% rise time = 76.3 ± 1.1 ms. Time-to-peak = 157.5 ± 2.7 ms; p < 0.001 for both; n 
= 10. Decay kinetics (iAChSnFR: tau = 258 ± 26.4 ms; M4-mediated IPSC: tau = 186.1 ± 5.4 ms, 
p < 0.05, n = 10) of fluorescence responses and M4-IPSCs. * = p < 0.05; ** = p < 0.01, *** = p < 
0.001, Mann-Whitney test. 
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Supplementary Figure S21. Active cholinergic projections in mouse forelimb motor cortex.  
(a) Coronal section of mouse primary motor cortex from a ChAT-Cre mouse infected with 
AAV2/1-Flex-CAG-GCaMP6s in nucleus basalis following 2 weeks of expression. Scale bar, 100 
µm. (b) Representative fluorescent traces from different axonal segments expressing GCaMP6s 
(labeled ROIs 1-6) in the motor cortex during quiet resting (left) and forward running (right, 
magenta shaded). (c) Distribution of cholinergic axon Ca2+ activity during quiet resting and 
forward running. *P < 0.05, paired Student’s t-test. 
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Supplementary Fig. S22.  Cortical neuronal activities of layer 2/3 pyramidal cells and Sst+ 
cells in response to evoked nucleus basalis (NB) activation.  (a) Schematic of experimental 
design with stimulating bipolar electrode placed in nucleus basalis and GCaMP6s expression in 
L2/3 neurons. GCaMP6s was selectively expressed in Sst+ neurons or in PCs (separate animals).  
Two-photon imaging was performed at the level of PC dendrites (L1) and somata (L2/3) and Sst+ 
axon fibers (L1) and somata (L2/3) (outlined in dashed box). (b) Fluorescence traces from 
representative L2/3 PC dendritic segments (left) and somata (right) expressing GCaMP6s before 
and after NB stimulation. (c) Average total integrated Ca2+ activity detected with GCaMP6s over 
10 sec before and after NB stimulation for apical tuft dendrites and L2/3 somata. Apical tuft 
dendrites (P < 0.001, n = 37) and somata (P < 0.05, n = 24) of L2/3 neurons displayed significant 
enhancement of calcium activity following NB stimulation. (d) Fluorescence traces from 
representative L1 Sst+ axonal segments (left) and L2/3 somata (right) expressing GCaMP6s before 
and after NB stimulation. (e) Average total integrated Ca2+ activity detected with GCaMP6s before 
and after NB stimulation for L1 Sst+ axonal segments and L2/3 Sst+ somata. L1 axonal segments 
(P < 0.001, n = 60) and L2/3 Sst+ somata (P < 0.05, n = 36) displayed significant enhancement of 
calcium activity following NB stimulation. The peak response of Sst+ cell activation occurred 5.5 
sec before the peak response of PCs. Data are presented as means ± s.e.m. *P < 0.05, ***P < 
0.001, paired Student’s t-test. 
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Supplementary Fig. S23.  iAChSnFR expression in primary motor cortex.  (a) Two-photon 
images of L2/3 neurons expressing iAChSnFR in wild-type (WT; left image) and Sst-Cre mice 
(right image). Scale bar, 20 µm. (b) Fluorescence measurements across somata of L2/3 PC (n = 
23) and Sst+ cells (n = 24). Nuclear signals were comparable or less than neuropil signals, 
demonstrating significant expression in the cytosol. Data are presented as means ± s.e.m. ***P < 
0.001, unpaired Student’s t-test. (c) Two-photon images across different cortical depths (thin 
branches of apical tuft, apical trunk, and deep basal dendrites; depth indicated) of L5 neurons 
expressing iAChSnFR. To enable L5 expression, AAV2/1-Flex-CAG-iAChSnFR was injected into 
Rbp4-Cre mice.  Scale bars, 20 µm. 
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Supplementary Fig. S24. Responses and modulation of iAChSnFR in Sst+ interneurons and 
pyramidal neurons of mouse motor cortex. 
(a) Average peak iAChSnFR signals from Sst+ dendrites (rest: 38 ± 2%, n =112; run: 50 ± 2%, n 
= 89; P < 0.001, t=4.293, df=199). (b) Average peak iAChSnFR signals from PC dendrites 
during quiet resting and forward running (rest: 45 ± 2%, n = 124; run: 66 ± 3%, n = 69, P < 
0.001, t=5.48, df=353), and in the presence of local eserine (rest: 65 ± 3%, n = 93, P < 0.001; 
t=5.71, df=353, run: 73 ± 4%, n = 71, P < 0.001, t=7.33, df=353). (c) Simultaneous activation of 
NB and 2-photon recording of iAChSnFR signals in L2/3 PC dendrites. Note that peak 
iAChSnFR signals are proportional to the amount of current delivered to NB (R2=0.33, P < 
0.001). (d) Representative fluorescence traces before and during 1 sec foot shock to hindlimb. (e) 
Distribution of peak iAChSnFR signals from dendrites of L2/3 PCs during foot shock as 
compared to no foot shock (no shock: 45 ± 2%, n = 124, shock: 59 ± 4%, n = 63, P < 0.001). 
Data are presented as means ± s.e.m. ***P < 0.001, unpaired Student’s t-test in a, e, and two-
way ANOVA followed by Bonferroni’s test in b. 
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Supplementary Fig. S25.  iAChSnFR performs better than GACh2.0 in detecting cholinergic 
signals. (a) Schematic of stimulation-imaging experiments in acute mouse entorhinal cortical 
(MEC) slices. (b) Representative fluorescence ΔF/F0 waveforms of iAChSnFR and GACh2.0 
expressing MEC neurons to trains of 20 electrical pulses at 0.5 Hz. (c) Values for peak ΔF/F0 
responses evoked by trains of 20 electrical pulses at 0.5 Hz (iAChSnFR: 1.2±0.2%, n=15 from 14 
animals; GACh2.0: 1.4±0.3%, n=14 from 8 animals; U=118.0, p=0.585) and 1 Hz (iAChSnFR: 
4.8±1.4%, n=16 from 15 animals; GACh2.0: 1.8±0.5%, n=14 from 8 animals; U=181.0, p=0.004) 
in iAChSnFR and GACh2.0 expressing entorhinal stellate neurons. (d) Left, values for peak ΔF/F0 
responses evoked by single electrical pulses in iAChSnFR and GACh2.0 expressing entorhinal 
stellate neurons (iAChSnFR: 1.0±0.1%, n=21 from 13 animals; GACh2.0: 0.2±0.04%, n=28 from 
7 animals; U=0.0, p<0.001). Right, values for decay time constants of fluorescence waveforms 
evoked by trains of 20 electrical pulses at 0.5 Hz and 1 Hz of iAChSnFR and GACh2.0 expressing 
entorhinal stellate neurons (iAChSnFR: 2.9±0.4 sec, n=32 from 12 animals; GACh2.0: 30.6±2.7 
sec, n=14 from 7 animals; U=0.0, p<0.001). Large gray dots indicate average responses and 
asterisks indicate p<0.05 (Mann-Whitney rank-sum non-parametric tests). 
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Supplementary Movie Legends 
 
Movie S1. Imaging responses of a hippocampal CA1 pyramidal neuron to ACh puff application. 
 
Movie S2. Imaging responses of the same CA1 pyramidal neuron to nicotine puff application. 
 
Movie S3. Imaging endogenous cholinergic transmission at an entorhinal stellate neuron. 
 
Movie S4. Imaging endogenous ACh release at individual release sites of an entorhinal stellate 
neuron. 
 
Movie S5. Imaging endogenous ACh release at an entorhinal astrocyte. 
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